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A B S T R A C T
Background
The beneficial effects of regular exercise for people living with or beyond cancer are becoming apparent. However, how to promote
exercise behaviour in sedentary cancer cohorts is not as well understood. A large majority of people living with or recovering from
cancer do not meet exercise recommendations. Hence, reviewing the evidence on how to promote and sustain exercise behaviour is
important.
Objectives
To assess the effects of interventions to promote exercise behaviour in sedentary people living with and beyond cancer and to address the
following questions: Which interventions are most effective in improving aerobic fitness and skeletal muscle strength and endurance?
What adverse effects are attributed to different exercise interventions? Which interventions are most effective in improving exercise
behaviour amongst patients with different cancers? Which interventions are most likely to promote long-term (12 months or longer)
exercise behaviour? What frequency of contact with exercise professionals is associated with increased exercise behaviour? What theo-
retical basis is most often associated with increased exercise behaviour? What behaviour change techniques are most often associated
with increased exercise behaviour?
Search methods
We searched the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library,
Issue 8, 2012), MEDLINE, EMBASE, AMED, CINAHL, PsycLIT/PsycINFO, SportDiscus and PEDro from inception to August
2012. We also searched the grey literature, wrote to leading experts in the field, wrote to charities and searched reference lists of other
recent systematic reviews.
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Selection criteria
We included only randomised controlled trials (RCTs) that compared an exercise intervention with a usual care approach in sedentary
people over the age of 18 with a homogenous primary cancer diagnosis.
Data collection and analysis
Two review authors working independently (LB and KH) screened all titles and abstracts to identify studies that might meet the
inclusion criteria, or that cannot be safely excluded without assessment of the full text (e.g. when no abstract is available). All eligible
papers were formally abstracted by at least two members of the review author team working independently (LB and KH) and using the
data collection form. When possible, and if appropriate, we performed a fixed-effect meta-analysis of study outcomes. For continuous
outcomes (e.g. cardiorespiratory fitness), we extracted the final value, the standard deviation of the outcome of interest and the number
of participants assessed at follow-up in each treatment arm, to estimate standardised mean difference (SMD) between treatment arms.
SMD was used, as investigators used heterogeneous methods to assess individual outcomes. If a meta-analysis was not possible or was
not appropriate, we synthesised studies as a narrative.
Main results
Fourteen trials were included in this review, involving a total of 648 participants. Only studies involving breast, prostate or colorectal
cancer were identified as eligible. Just six trials incorporated a target level of exercise that could meet current recommendations. Only
three trials were identified that attempted to objectively validate independent exercise behaviour with accelerometers or heart rate
monitoring. Adherence to exercise interventions, which is crucial for understanding treatment dose, is often poorly reported. It is
important to note that the fundamental metrics of exercise behaviour (i.e. frequency, intensity and duration, repetitions, sets and
intensity of resistance training), although easy to devise and report, are seldom included in published clinical trials.
None of the included trials reported that 75% or greater adherence (the stated primary outcome for this review) of the intervention
group met current aerobic exercise recommendations at any given follow-up. Just two trials reported six weeks of resistance exercise
behaviour that would meet the guideline recommendations. However, three trials reported adherence of 75% or greater to an aerobic
exercise goal that was less than the current guideline recommendation of 150 minutes per week. All three incorporated both supervised
and independent exercise components as part of the intervention, and none placed restrictions on the control group in terms of exercise
behaviour. These three trials shared programme set goals and the following behaviour change techniques: generalisation of a target
behaviour; prompting of self-monitoring of behaviour; and prompting of practise. Despite the uncertainty surrounding adherence in
many of the included trials, interventions caused improvements in aerobic exercise tolerance at 8 to 12 weeks (from 7 studies, SMD
0.73, 95% confidence interval (CI) 0.51 to 0.95) in intervention participants compared with controls. At six months, aerobic exercise
tolerance was also improved (from 5 studies, SMD 0.70, 95% CI 0.45 to 0.94), but it should be noted that four of the five trials
used in this analysis had a high risk of bias, hence caution is warranted in interpretation of results. Attrition over the course of these
interventions is typically low (median 6%).
Authors’ conclusions
Interventions to promote exercise in cancer survivors who report better levels of adherence share some common behaviour change
techniques. These involve setting programme goals, prompting practise and self-monitoring and encouraging participants to attempt to
generalise behaviours learned in supervised exercise environments to other, non-supervised contexts. However, expectingmost sedentary
survivors to achieve current guideline recommendations of at least 150 minutes per week of aerobic exercise is likely to be unrealistic.
As with all well-designed exercise programmes in any context, prescriptions should be designed around individual capabilities, and
frequency, duration and intensity or sets, repetitions, intensity or resistance training should be generated on this basis.
P L A I N L A N G U A G E S U M M A R Y
Title: Interventions for promoting habitual exercise in people living with and beyond cancer
Question: What are the most effective ways to improve and sustain exercise behaviour in cancer survivors, that is, people living with
and beyond cancer?
Background: Being regularly active for people living with and beyond cancer can have a wide range of beneficial effects. These range
from improving quality of life to improving physical function. It might also reduce the risk of cancer recurrence and of dying from
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cancer. We know that most people living with and beyond cancer are not regularly physically active. So, we need to understand how to
get those individuals who are not currently exercising to begin to be active and how to help them maintain this change in behaviour.
Study characteristics: We included only studies that compared an exercise intervention with a usual care comparison. Only studies
including sedentary people over the age of 18 with the same cancer diagnosis were eligible. Participants must have been put in a group
at random. We searched for evidence from research databases up to August 2012.
Key results: This review included 14 trials involving 648 participants. Evidence suggests that we have a poor understanding of how
to encourage people living with and beyond cancer to meet current exercise recommendations. Furthermore, how trial investigators
report what their exercise programme involved and how much of it the participants actually did is not good. However, we did find
some evidence that setting exercise goals, prompting people to exercise, getting people to monitor their own behaviour and getting
people to think about how to do exercise outside of a supervised environment could be helpful. In addition, we found some evidence
suggesting that study participants are better able to tolerate the exertion of undertaking exercise for up to six months.
Quality of the evidence: The main problems that we found regarding the quality of studies in this review included not knowing how
study investigators conducted randomisation for the trials, and whether investigators who were doing trial assessments knew to which
group the person they were assessing had been randomly assigned.
B A C K G R O U N D
Description of the condition
Approximately 25million people worldwide are living with cancer
(Kamangar 2006). As such, cancer represents one of the largest
global health problems. Breast, prostate and bowel cancer account
for most of the survivorship population (around 52%) (Maddams
2009). Recent evidence fromMacmillanCancer Support indicates
that cancer survival rates have much improved over the past 30
years (Macmillan Cancer Support 2012). Coleman 2011 reported
that relative survival has improved in breast, colorectal, lung and
ovarian cancer over the period 1995-2007. This is good news for
people living with themore common cancers who are undergoing,
or recovering from, treatment. However, this also means that sur-
vivors are living longer with the consequences of cancer treatment,
which frequently manifest as fatigue, reduced functional capacity
and poorer health-related quality of life (HRQoL). Further, cancer
survivors are significantly more likely to report poor health out-
comes compared with those with no history of cancer or a chronic
condition (Elliott 2011). Throughout this review, we will define
a cancer survivor as someone ’living with or beyond cancer’, in
line with the Macmillan Cancer Support definition (Macmillan
Cancer Support 2011).
Description of the intervention
The goal of any exercise regime is a sustained physiological chal-
lenge that, over time, will induce a spectrum of beneficial cardio-
vascular, respiratory, musculoskeletal, neurological and metabolic
adaptations. In the context of living with or beyond disease, it
is these adaptations that will likely translate to a range of bene-
fits from improvements in HRQoL and physical function to re-
ducing disease progression, secondary recurrence and mortality
(Fong 2012; Ibrahim 2011). Evidence for this in cancer popula-
tions ranges from epidemiological observations to cause and effect
derived from randomised controlled trials (RCTs). As such, the
potential for habitual exercise to act as a useful adjunctive ther-
apy is a growing area of research interest (Rock 2012). The UK
Chief Medical Officer recommends that in adults, weekly activity
should add up to at least 150 minutes of moderate intensity ex-
ercise, performed in bouts of 10 minutes or longer (Department
of Health 2011; Rock 2012). For example, this could translate to
30 minutes of exercise that raises heart rate and breathing rate,
five times per week. Alternatively, 75minutes of vigorous intensity
activity spread across the week can confer similar benefits. The
general consensus is that such guidelines are also appropriate for
adult cancer survivors (Rock 2012). However, encouraging people
to participate in regular exercise from a background of a sedentary
lifestyle is difficult, requiring attention to psychosocial and be-
havioural influences on exercise, as well as the physiological basis
of exercise (Greaves 2011). A still greater challenge is to provide a
support structure for physical activity until it becomes a pattern of
sustained healthy behaviour. In this review, interventions of inter-
est include any programmes that promote increased exercise be-
haviour in people living with and beyond cancer, with a particular
focus on long-term change in exercise behaviour.
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How the intervention might work
RCTs in people living with and beyond cancer have assessed vari-
ous interventions aimed at promoting both short- and long-term
exercise participation.These include approaches such as supervised
exercise (Bourke 2011); home-based exercise (Courneya 2003);
group-based patient education (Carmack Taylor 2006); informa-
tion leaflets (Demark-Wahnefried 2007); cognitive behavioural
therapy approaches (May 2008) and motivational interviewing
(Bennett 2007). Tailored exercise interventions commonly com-
prise aerobic exercise training, resistance (strength) training or a
combination of both, with or without behaviour change support.
These approaches tend to vary in the extent to which they are
based on behaviour change theory or employ specific behaviour
change techniques.
Why it is important to do this review
A large majority of people living with and beyond cancer are
not regularly active (for the purposes of this review, referred to
as “sedentary”) (Department of Health 2012). Systematic reviews
and meta-analyses of interventions promoting exercise partici-
pation in people living with and beyond cancer have reported
a range of benefits, including reduced fatigue and improved
functional capacity/physical fitness and HRQoL (Cramp 2012;
Demark-Wahnefried 2007; Fong 2012; McNeely 2006; Pekmezi
2011; Mishra 2012a; Mishra 2012b). However, most of the cur-
rent evidence comes from trials with short-term interventions and
follow-up, with any benefits likely to be transient if exercise be-
haviour is not sustained. Understanding which interventions are
most efficacious in supporting long-term exercise behaviour would
be very useful (Bourke 2012), not just because of theHRQoL ben-
efits, but emerging observational data suggest that being regularly
active can reduce the chances of dying from cancer after diagnosis.
Physical activity in observational studies is usually estimated as the
self-reported time spent exercising and is reported as metabolic
equivalent task (MET)-hours per week, using typical MET values
for specific activities (Ainsworth 2011). In breast, prostate and
bowel cancer, increased post-diagnosis exercise behaviour has been
reported to reduce cancer-specific mortality risk by 32% to 61%,
with around 18 to 27 MET-hours per week of exercise confer-
ring benefit (Haydon 2006; Holick 2008; Holmes 2005; Kenfield
2011; Meyerhardt 2006; Meyerhardt 2009; Nilsen 2006). Fur-
thermore, providing an understanding of which behaviour change
theories and behaviour change techniques are most efficacious in
improving exercise behaviour will facilitate optimal design for fu-
ture exercise interventions.
In the UK, the National Cancer Survivorship Initiative has high-
lighted physical symptoms as a consequence of treatment as an
area of researchwith the highest priority (Richards 2011). Further-
more, from an international perspective, the recent Lancet On-
cology Commission called for novel, more effective and less toxic
interventions for delivering affordable cancer care (Sullivan 2011).
Promoting habitual exercise participation could satisfy both of
these high priority agendas.
We have deliberately chosen the term “habitual” over “regular”
to reflect the intention to assess which interventions could im-
prove and sustain exercise behaviour. “Regular exercise” can be
applied to both short-term and long-term contexts, where as a
“habitual” exerciser indicates a sustained and regular pattern of
behaviour. Furthermore, “habitual” refers to the process of be-
havioural “habit forming”, which suggests an automaticity of be-
haviour, thereby improving maintenance of behaviour change
(Gardner 2011; Verplanken and Melkelvik 2009). Systematically
reviewing variations in frequency, intensity and duration of ex-
ercise achieved, the theoretical basis of the intervention and be-
haviour change techniques used, adherence to these interventions,
attrition, reported adverse events and duration of sustained mean-
ingful exercise behaviour is crucial for informing future trial de-
sign (in under-studied cancer populations) and for facilitating the
integration of exercise therapy into existing care pathways (when
the evidence demonstrates efficacy for a given intervention). The
purpose of this review is to summarise the existing literature on the
effects of exercise-promoting interventions on short- and longer-
term exercise behaviour in previously sedentary people living with
and beyond cancer.
O B J E C T I V E S
Primary objective
To assess the effects of interventions to promote exercise behaviour
in sedentary people living with and beyond cancer
Secondary objectives
To address the following questions:
• Which interventions are most effective in improving
aerobic fitness and skeletal muscle strength and endurance?
• What adverse effects are attributed to different exercise
interventions?
• Which interventions are most effective in improving
exercise behaviour amongst patients with different cancers?
• Which interventions are most likely to promote long-term
(12 months or longer) exercise behaviour?
• What frequency of contact with exercise professionals is
associated with increased exercise behaviour?
• What theoretical basis is most often associated with
increased exercise behaviour?
• What behaviour change techniques are most often
associated with increased exercise behaviour?
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M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs that allocated participants or clusters of participants by a
random method to an exercise-promoting intervention compared
with usual care or ’waiting list’ control. We included only RCTs
that aimed to improve exercise behaviour compared with a usual
care comparison group. We included studies conducted both dur-
ing and after primary treatment or during active monitoring. Only
interventions that included a component targeted at increasing
aerobic exercise and/or resistance exercise behaviour will be in-
cluded in this review. We did not include studies of heteroge-
neous cancer cohorts (i.e. participants with different primary can-
cer sites). We did not include studies in ’at risk’ populations (i.e.
studies involving individuals who have risk factors for cancer but
who have not yet been diagnosed with the disease) that addressed
primary prevention research questions.
Types of participants
We included only trials involving adults (18 years of age or older)
who had a sedentary lifestyle at baseline (i.e. not undertaking 30
minutes or more of exercise of at least moderate intensity, three
days per week, or 90 minutes in total of moderate intensity exer-
cise per week). Participants must have been histologically or clini-
cally diagnosed with cancer regardless of sex, tumour site, tumour
type, tumour stage and type of anticancer treatment received. We
excluded trials directed specifically at end-of-life-care patients and
individuals who were currently hospital inpatients.
Types of interventions
For the purposes of this review, the phrases ’exercise’ and ’phys-
ical activity’ were used interchangeably. Definitions of exercise,
related terms and nomenclature that describe the performance of
exercise must adhere to principles of science and must satisfy the
Système International d’Unités (SI), which was adopted univer-
sally in 1960. Hence, we referred to the appropriate, combined
definition that applies to all situations: “A potential disruption to
homeostasis by muscle activity that is either exclusively or in com-
bination, concentric, eccentric or isometric” (Winter and Fowler
2009). Investigators must have reported frequency, duration and
intensity of aerobic exercise behaviour or frequency, intensity, type,
sets, repetitions and pattern of resistance of exercise behaviour that
was prescribed in the intervention.
We acknowledge that the maximal aerobic capacity (VO2max)/
peak is often the most informative metric for setting aerobic ex-
ercise intensity; however, given the nature of the population in-
volved (elderly, potentially with multiple co-morbidities), it is of-
ten difficult to conduct maximal testing protocols to prescribe in-
tensity on the basis of these measures because of the requirements
for medically qualified staff to be present during assessment. As
such, for reasons of pragmatism, we accept that exercise intensity
is more frequently reported in the cohorts in terms of age-pre-
dicted maximum heart rate max (HRmax ) or on the Borg rating
of perceived exertion (RPE) scale (Borg 1982). The interventions
in this review were categorised as achieving a mild (less than 60%
HRmax /10 RPE or less), moderate (60% to 84%HRmax /11 to 14
RPE) or vigorous (85%HRmax or more/15 RPE or more) exercise
intensity.
Types of outcome measures
Primary outcomes
Aerobic exercise behaviour as measured by:
• exercise frequency (number of bouts per week);
• exercise duration (total minutes of exercise achieved);
• exercise intensity (e.g. % HRmax , RPE);
• estimated energy expenditure from free living physical
activity (e.g. from accelerometer readings [where available]);
• adherence to the exercise intervention (% of exercise
sessions completed/attended);
• total duration of intervention when ≥75% adherence is
achieved (in weeks); and
• total duration of sustained exercise behaviour meeting
American Cancer Society guidelines for exercise in people living
with and beyond cancer (Rock 2012; i.e. aim to exercise at least
150 minutes per week, with at least two days per week of
strength training).
Resistance exercise behaviour as measured by:
• exercise frequency (number of bouts per week);
• exercise intensity (e.g. % of 1 repetition max or % of body
mass);
• type of exercise (e.g. free weights, body weight exercise);
• repetitions;
• sets; and
• pattern (quantification of rest period in relation to sets and
repetitions).
Secondary outcomes
• Change in aerobic fitness or exercise tolerance (maximal or
submaximal when measured directly or by a standard field test).
• Change in skeletal muscle strength and endurance.
• Adverse effects.
• Trial recruitment rate.
• Intervention attrition rate.
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Interventions were judged as successful in achieving exercise goals
as identified in the study methods if investigators reported at least
75% adherence over a given follow-up period. Data on compli-
ance with the intervention were quantified in terms of number
of prescribed exercise sessions completed as a proportion of the
total set. The intervention must have included at least 6 weeks
of follow-up. Interventions were categorised according to whether
they were based on a behaviour change theory (e.g. control the-
ory, social cognitive theory; Bandura 2000; Bandura 2002; Carver
1982). This relates to the National Institute for Health and Clini-
cal Excellence (NICE) guidance for behaviour change, which rec-
ommends that clinicians should be explicit about the theoretical
constructs on which interventions are based (NICE 2007). Inter-
ventions were also categorised using the ‘Coventry, Aberdeen &
London Refined’ (CALO-RE) taxonomy (Michie 2011). This
is a validated taxonomy of behaviour change techniques (BCTs)
that can be used to help people change their exercise behaviour.
Categorising interventions according to this taxonomy resulted in
a better understanding of which techniques are employed by cur-
rent interventions and how they are related to short- and longer-
term exercise behaviour change.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases.
• CENTRAL (Cochrane Central Register of Controlled
Trials).
• MEDLINE (Medical Literature Analysis and Retrieval
System Online).
• EMBASE (the Excerpta Medica database).
• AMED (Allied and Alternative Medicine Database; covers
occupational therapy, physiotherapy and complementary
medicine).
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature).
• PsycINFO (Database of the American Psychological
Association).
• SportDiscus (Sports Evidence Database).
• PEDro (Physiotherapy Evidence Database).
The MEDLINE search strategy is presented in Appendix 2. For
databases other than MEDLINE, we adapted the search strat-
egy accordingly: EMBASE (Appendix 3), AMED (Appendix 4),
CINAHL (Appendix 5) and PsycINFO (Appendix 6).
The search strategies were developed with the Cochrane Gynae-
cological Cancer Group Information Manager (Jane Hayes) and
included MeSH and text word terms as appropriate.
We attempted to identify all relevant articles on PubMed, using
the ’related articles’ feature, and performed further searches for
newly published articles.
Searching other resources
We searched reference lists of retrieved articles and published re-
views on the topic. We contacted the principal investigators of the
identified studies, as well as 10 national and international experts
in the field, to ask whether they were aware of any other relevant
unpublished studies in the area.
We expanded the database search by identifying additional relevant
studies for this review, including unpublished studies and refer-
ences in the grey literature. This was done by searching the Open-
Grey database (http://www.opengrey.eu/), which includes techni-
cal or research reports, doctoral dissertations, conference papers
and other types of grey literature. We also searched the following
clinical trials web pages:
• http://www.who.int/ictrp/en;
• Metaregister (http://www.controlled-trials.com/rct);
• ClinicalTrials.gov (http://www.clinicaltrials.gov); and
• http://www.cancer.gov/clinicaltrials.
We screened the full text of any relevant papers identified through
these searches. We also approached the principal investigators
and major co-operative groups active in this area to ask for
relevant data. Furthermore, we wrote to Cancer Research UK
(CRUK),Macmillan Cancer Support, theWorld Cancer Research
Fund (WCRF), the Association for International Cancer Research
(AICR), the American Association for Cancer Research (AACR),
the American Cancer Society (ACS) and the American Society of
Clinical Oncology (ASCO) to enquire about relevant unpublished
papers.
Data collection and analysis
Selection of studies
We imported results from each database into the reference man-
agement software package Endnote, from which we removed du-
plicates and selected relevant articles for screening. After training
on the first 100 references retrieved from two different databases
was provided to ensure a consistent approach, two review authors
(LB and KH) worked independently to screen all titles and ab-
stracts to identify studies that met the inclusion criteria, or that
could not be safely excluded without assessment of the full text
(e.g. when no abstract was available). Disagreements were resolved
by discussion with another review author (ST or DR). Full texts
were retrieved for these articles.
After training was provided to ensure a consistent approach to
study assessment and data abstraction, two review authors worked
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independently to assess the retrieved full texts. We linked to-
gether multiple publications and reports on the same study. Stud-
ies that appeared to be relevant but are excluded at this stage were
listed in the ’Characteristics of excluded studies’ table.We resolved
disagreements by discussion with other group members. We at-
tempted to contact study corresponding authors if we could not
access a full text (e.g. if only an abstract was available), if we re-
quired more information to determine whether a study could be
included (e.g. to determine baseline exercise behaviour of a cohort)
or if we required supplementary information about an already el-
igible trial (please also see Excluded studies).
Data extraction and management
We extracted the following data.
• Study details: author, year, research question/study aim;
country where the research was carried out; recruitment source
(e.g. consecutive sampling from outpatient appointments;
advertising in the community; convenient sample from support
groups); inclusion and exclusion criteria; study design (cluster
RCT, non-cluster RCT, single centre or multi-centre); length of
follow-up; description of usual care.
• Intervention details: categorisation of intervention (e.g.
supervised, independent, educational); setting (e.g. dedicated
exercise facility, community, home); exercise prescription
components (e.g. aerobic exercise, resistance exercise, stretching);
theoretical basis, behaviour change techniques (using CALO-RE
taxonomy), frequency of contact with an exercise professional.
• Participant characteristics: primary cancer diagnosis; any
cancer treatment currently undertaken; metastatic disease status;
age; sex; socio-economic status; ethnicity; reported
comorbidities.
• Resulting exercise behaviour: method of measuring exercise
(e.g. self-report questionnaire). Numbers of participants
randomly assigned and assessed at specified follow-up points.
Frequency, duration, intensity of aerobic exercise achieved;
frequency, intensity, type, sets, repetitions and pattern of
resistance exercise achieved; total duration of the intervention
and total duration of sustained meaningful exercise behaviour as
a result of the intervention. Adherence to the intervention; rate
of attrition and adverse effects reported.
• Resulting change in other outcomes: changes in aerobic
fitness and estimated energy expenditure from free living
physical activity.
Two members of the group worked independently (LB and KH)
to abstract data from all eligible papers using the data collection
form. Data were to be entered into the Cochrane Collaboration’s
statistical software, Review Manager 2011, by one review author
and checked by a second review author.
Assessment of risk of bias in included studies
Risk of bias and methodological quality were assessed in accor-
dance with the Cochrane Collaboration’s tool for assessing risk of
bias (Higgins 2011). The tool includes the following seven do-
mains:
• sequence generation (method of randomisation);
• allocation concealment (selection bias);
• blinding (masking) of participants and personnel
(detections bias);
• blinding (masking) of outcome assessors (detection bias);
• incomplete outcome data;
• selective outcome reporting; and
• other sources of bias.
However, we did not include whether participants were blind to
their allocation of intervention or to control groups, as it is often
not possible (e.g. in a supervised exercise setting) to blind partici-
pants to an intervention while promoting exercise behaviour. Two
review authors (LB and KH) applied the risk of bias tool indepen-
dently, and differences were resolved by discussion with a third
review author (ST or DR). We summarised results in both a risk
of bias graph and a risk of bias summary. Results of meta-analyses
were interpreted in light of the findings with respect to risk of bias.
We contacted study authors to ask for additional information or
for further clarification of study methods if any doubt surrounded
potential sources of bias. Individual risk of bias items can be seen
in Appendix 7.
Measures of treatment effect
For the purposes of this review, all exercise behaviour was syn-
thesised as specified in the primary outcomes. For comparison of
measures of change in fitness levels or estimated energy expen-
diture from free living physical activity, please see the section on
“Continuous data”, Data synthesis.
Unit of analysis issues
We included no cross-over trials in this review because of the high
risk of contamination. It can be very difficult to “wash out” exer-
cise behaviour. Cancer survivors in particular can be a highly mo-
tivated cohort, and significant contamination has been reported
even in conventional RCT settings (Courneya 2003;Mock 2005).
Indeed, some trials have reported significant maintenance up to
three months after cessation of the intervention.(Bourke 2011).
Hence this learning effect distorts results. Furthermore, asking in-
dividuals to revert to sedentary behaviour could be considered un-
ethical (Das and Horton 2012). Therefore, any cross-over trials
identified were rejected at the title and abstract screening stage.
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Dealing with missing data
Weassessedmissingdata anddropout rates for each of the included
studies and reported the numbers of participants included in the
final analysis as a proportion of all participants included in the
study. We assessed the extent to which studies conformed to an
intention-to-treat analysis.
Assessment of heterogeneity
Consistency of results was assessed visually and through exami-
nation of the I2 statistic, a quantity that describes approximately
the proportion of variation in point estimates that is due to het-
erogeneity rather than sampling error. I2 greater than or equal to
50% was considered significant heterogeneity. We addressed this
by performing a sensitivity analysis that excludes any heteroge-
neous trials. We supplemented this with a test of homogeneity
to determine the strength of evidence that the heterogeneity is
genuine. When significant statistical heterogeneity was detected,
differences in characteristics of the studies or other factors were
explored as possible sources of explanation. Any differences were
summarised in a narrative synthesis.
Assessment of reporting biases
Publication bias
We intended to examine funnel plots corresponding tometa-anal-
ysis of the primary outcomes to assess the potential for small study
effects such as publication bias if a sufficient number of studies
(i.e. more than 10) was identified. However, this was not the case;
therefore this step was not included in the analysis.
Data synthesis
Continuous data
For continuous outcomes (e.g. cardiorespiratory fitness), we ex-
tracted the final value, the standard deviation of the outcome of
interest and the number of participants assessed at endpoint for
each treatment arm at the end of follow-up, to estimate standard-
ised mean differences between treatment arms.
Dichotomous outcomes
For dichotomous outcomes (e.g. adverse effects, deaths), if it was
not possible to use a hazard ratio, we extracted the number of
participants in each treatment arm who experienced the outcome
of interest and the number of participants assessed at endpoint, to
estimate a risk ratio.
Meta-analysis
When possible, and if appropriate, we performed a meta-analysis
of review outcomes. If statistical heterogeneity was noted, a meta-
analysis was performed using a random-effects model. A fixed-
effectmodel was to be used if no significant statistical heterogeneity
was observed.
When possible, all data extracted were those relevant to an inten-
tion-to-treat analysis inwhich participants were analysed in groups
to which they were assigned. We noted the time points at which
outcomes were collected and reported.
Subgroup analysis and investigation of heterogeneity
If a sufficient number of studies were identified, we performed
subgroup analyses for the following.
• Cancer site.
• Type of intervention (i.e. supervised, home-based, etc).
• Age of individuals (i.e. elderly vs non-elderly).
• Current treatment (currently undergoing treatment vs not
currently undergoing treatment).
• Participants with metastatic disease (metastatic cohort vs
non-metastatic cohort).
• Accordance with behaviour change theory.
• Interventions in obese individuals (mean body mass index
(BMI) of intervention group > 30 kg/m2 vs mean BMI of
intervention group < 30 kg/m2).
Sensitivity analysis
Methodological flaws were judged using the Cochrane Collabora-
tion’s tool for assessing risk of bias to identify studies of high and
low quality (Higgins 2011). Sensitivity analyses were performed
with the studies of low quality excluded.
R E S U L T S
Description of studies
Please see Table 1, ’Summary of included studies’. See ’
Characteristics of included studies’; ’Characteristics of excluded
studies’; ’Characteristics of studies awaiting classification’; and
’Characteristics of ongoing studies’.
Results of the search
Figure 1 illustrates the process of the literature search and study
selection for the review. We identified 4827 unique records
from research databases and 732 records through grey literature
and “snowballing” techniques, which included reference checking
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from recent large systematic reviews (Fong 2012; Mishra 2012a;
Mishra 2012b). Given that the details of prescribed exercise are
rarely reported in manuscript abstracts (e.g. frequency, intensity,
duration of exercise prescription), this led to evaluation of a large
number of manuscripts at full text stage (n = 402). From these
full text articles, 377 manuscripts were excluded, leaving 25 pub-
lications included in the review. Reasons for excluding these 377
publications are covered in the Excluded studies section below.
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Figure 1. PRISMA flow diagram.
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Included studies
After consensus agreement was reached by review authors (LB and
KH), 14 trials were included in this review (Bourke 2011a; Bourke
2011b; Cadmus 2009; Daley 2007a; Drouin 2005; Hayes 2009;
Kaltsatou 2011; Kim 2006;McKenzie 2003;Musanti 2012; Perna
2010; Pinto 2003; Pinto 2005; Pinto 2011). We also included in
our analysis 11 follow-up papers that performed secondary anal-
yses of data from a primary RCT. We sent 116 emails to request
unpublished information for manuscripts that were unclear in re-
porting relative to our inclusion/exclusion criteria. We were able
to include 15 and to exclude 34 published manuscripts on the
basis of information received in correspondence from authors.
Only RCTs were included in the review. All included trials used a
parallel-group designwith baseline assessment and follow-up of 12
months maximum. All included trials were conducted using par-
ticipant level randomisation. The format of reporting precluded
data extraction for meta-analytical combination in two studies
(Drouin 2005; Pinto 2003). Sample size ranged from 14 to 108,
with a total of 648 participants included in this review (mean age
range 51 to 72).
Participants
Most trials were conducted in breast cancer survivors (Cadmus
2009; Daley 2007a; Drouin 2005; Hayes 2009; Kaltsatou 2011;
Kim 2006; McKenzie 2003; Musanti 2012; Perna 2010; Pinto
2005; Pinto 2003); only two trials involved colorectal cancer
(Bourke 2011a; Pinto 2011), and one prostate cancer (Bourke
2011b). Of these trials, eight included participants who were cur-
rently undergoing active treatment inclusive of hormone-based
therapy (Bourke 2011b; Cadmus 2009; Daley 2007a; Drouin
2005; Kim 2006; Musanti 2012; Perna 2010; Pinto 2005). We
found only one study that reported data from participants with
metastatic disease (Bourke 2011b) and two that were conducted in
obese cohorts (i.e. mean BMI > 30 kg/m2; Cadmus 2009; Drouin
2005). An overwhelming proportion of participants were white,
and only one study reported data from an ethnically diverse sam-
ple (Perna 2010). Comorbidities at baseline were largely unclear
or unreported; only Daley 2007a and Hayes 2009 reported on
proportions with lymphedema, and Perna 2010 reported on pro-
portions with clinically relevant depression scores.
Interventions
Eight trials prescribed exclusively aerobic exercise (Cadmus 2009;
Daley 2007a; Drouin 2005; Kaltsatou 2011; Kim 2006; Pinto
2003; Pinto 2005; Pinto 2011); the remaining RCTs used a mix
of aerobic and resistance training (no exclusively resistance train-
ing studies met our inclusion criteria). Seven trials used a com-
bination of supervised and home-based exercise (Bourke 2011a;
Bourke 2011b; Cadmus 2009; Hayes 2009; Kim 2006; Perna
2010; Pinto 2003), four trials opted to use an exclusively home-
based design (Drouin 2005; Musanti 2012; Pinto 2005; Pinto
2011), and only three were exclusively supervised trials (Daley
2007a; Kaltsatou 2011; McKenzie 2003). Contact with exercise
professionals or study researchers ranged from 20 times over 12
weeks (Hayes 2009) to weekly phone calls after an initial one-
to-one exercise consultation (Pinto 2005; Pinto 2011). Of note,
seven trials (Drouin 2005; Kaltsatou 2011; Kim 2006; McKenzie
2003; Pinto 2003; Pinto 2005; Pinto 2011) placed restrictions on
the control group regarding exercise behaviour during the course
of the trial, usually taking the form of direct instruction to refrain
from changing exercise behaviour. Just six trials incorporated pre-
scriptions that would meet the Rock 2012 recommendations for
aerobic exercise (i.e.150 minutes per week; Cadmus 2009; Pinto
2011) or resistance exercise (i.e. resistance training strength train-
ing exercises at least two days per week; Bourke 2011a; Bourke
2011b; Musanti 2012; Perna 2010). Only three trials were iden-
tified that attempted to objectively validate independent exercise
behaviour with accelerometers or heart rate monitoring (Cadmus
2009; Pinto 2005; Pinto 2011).
Full details of intervention (behaviour change technique (BCT))
coding according to the CALO-RE taxonomy can be seen in Table
2. Of the 14 interventions provided, only five were explicitly based
on a theoretical model (Daley 2007a; Musanti 2012; Perna 2010;
Pinto 2005; Pinto 2011); the trans-theoretical model was most
common.All interventions had a target exercise level set by the pro-
gramme. Only sjx trials set exercise goals in conjunction with par-
ticipants (BCT # 5). In addition, all prompted practise of the be-
haviour (BCT #26), and all but four (Bourke 2011a; Hayes 2009;
McKenzie 2003; Pinto 2005) reported providing instruction on
how to perform the behaviour (BCT #21), although it may be an-
ticipated that this did occur but just was not reported. Other com-
mon BCTs included setting of graded tasks (i.e. increased exercise
duration or intensity over time) and self-monitoring of behaviour
(exercise) and outcomes of behaviour (e.g. heart rate), although it
is not clear for all interventions whether this was done primarily
for data collection or as a mechanism of behaviour change. It is
important to note that when monitoring did occur (BCT #16),
feedback on performance (BCT #19) was provided in only 4/10
(Cadmus 2009; Perna 2010; Pinto 2005; Pinto 2011). Similarly,
in only two of six interventions (Daley 2007a; Perna 2010) for
which participants had some input into setting of goals were these
reviewed (BCT #10). Of note, few interventions (Cadmus 2009;
Daley 2007a; Kim 2006; Perna 2010) reported providing infor-
mation on the consequences of behaviour (BCT #1), although less
than half reported problem solving with barriers identified (BCT
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#8) and solutions facilitated (Bourke 2011b; Cadmus 2009; Daley
2007a; Perna 2010; Pinto 2005; Pinto 2011). Only three trials
used techniques to increase social support (BCT #29; Cadmus
2009; Daley 2007a; Perna 2010).
Excluded studies
Reasons for excluding published studies included the following.
• Non-RCTs (e.g. review manuscripts, comment/editorial
articles).
• Mixed cancer cohorts or cohorts that included non-cancer
populations.
• Trials that failed to describe essential metrics of exercise
prescription used in the intervention (e.g. frequency, intensity,
duration).
• Trials involving active participants at baseline.
• Trials involving hospital inpatients.
• Interventions that provided follow-up of less than 6 weeks.
• Trials involving participants younger than 18 years of age.
Because of the volume of studies identified by the search, only the
first occurrence of an exclusion criterion was noted in the publi-
cation, although frequently, trials exhibited several of the criteria
listed above. Therefore, it was neither valid nor informative to
present the number of papers excluded under each of the reasons
listed above. The extent of exclusion at the full text screening stage
(377 publications excluded from402) provided the first indication
of problems associated with quality of reporting in this research
area. We sent emails to 116 corresponding authors to request ad-
ditional information (regarding included studies, excluded studies
and studies that we could not access) to determine eligibility and
to supplement published data for this review.
Only a subset of excluded studies could be included in the
’Characteristics of excluded studies’ section. This is a result of the
huge volume of trials that had to be full text screened (N = 402)
and the high proportion (around 90%) that were excluded. In ac-
cordance with editorial advice, we divided this large number (N =
365) into initially unclear trials that required further investigation
(N = 76) and those that clearly were not eligible after full text
had been retrieved (N = 289). This approach is analogous to the
approach adopted in recent reviews (Galway 2012) and is detailed
in the existing PRISMA diagram (Figure 1).
Risk of bias in included studies
Only three trials were judged not to include a high risk of bias
(Bourke 2011a; Cadmus 2009; Drouin 2005). Full results of the
methodological quality assessment for allocation bias, blinding,
incomplete data outcome and selective reporting (along with jus-
tifications) are covered in the risk of bias tables for each study and
are illustrated in Figure 2 and Figure 3. Seven trials stated that
an intention-to-treat analysis was used (Bourke 2011a; Bourke
2011b; Cadmus 2009; Daley 2007a; Perna 2010; Pinto 2005;
Pinto 2011).
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Most trials (8 out of 14) were not clear in their description of
concealment in randomisation allocation. However, no trial was
judged to have a high risk of bias in this respect.
Blinding
Only four trials explicitly stated whether they had undertaken
blinding of study assessors (Bourke 2011a; Bourke 2011b; Daley
2007a; Hayes 2009). The remaining trials did not include enough
information for the review authors to make a definitive judgement
on this criterion.
Incomplete outcome data
Four trials were judged to have been subject to incomplete data
outcome bias. Bourke 2011b reported a 44% attrition at six
months of follow-up; Kim 2006 reported data from only 41 of
74 participants randomly assigned; Musanti 2012 reported that
13 women (24%) did not complete their assigned 12-week pro-
gramme; and Pinto 2003 did not report control group data for the
exercise tolerance test. However, most studies (8 out of 14) were
explicit in their reporting of outcomes.
Selective reporting
Most studies reported all listed outcomes; however, three trialswere
judged to omit outcomes from their results reporting. Musanti
2012 did not report waist and upper, mid and lower arm circum-
ference outcomes; Pinto 2003 reported none of the physiological
assessments in the control group at 12 weeks of follow-up; Pinto
2011 did not report data derived from the use of accelerometers.
Other potential sources of bias
Other sources of bias found in the included trials that are worth
highlighting include adherence data missing or not clear (Hayes
2009; Kaltsatou 2011; McKenzie 2003; Musanti 2012); high at-
trition at follow-up (Bourke 2011b; Pinto 2003); low recruit-
ment rate (Bourke 2011a); significant differences in participants
excluded from trial analysis/dropouts (Kim 2006; Musanti 2012;
Pinto 2003); numbers randomly assigned to trial arms with trial
completion rate unclear (Perna 2010); significant differences in
cohorts at baseline (Musanti 2012; Pinto 2003; Pinto 2005); and
inconsistencies between objective and subjective measures of exer-
cise behaviour (Pinto 2005; Pinto 2011). Insufficient information
was reported to permit a judgement about any single element of
bias because of lack of data in Cadmus 2009; Drouin 2005; Hayes
2009; Kaltsatou 2011; Kim 2006; McKenzie 2003; Pinto 2003;
Pinto 2005; and Pinto 2011.
Effects of interventions
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Primary outcomes
Please see Table 1, ’Summary of included studies’. As it is not
meaningful to interpret individually the componentmetrics of aer-
obic (frequency, intensity and duration) or resistance exercise (fre-
quency, intensity, type of exercise, sets and repetitions) behaviour,
these primary outcomes are presented in the narrative synthesis
below of interventions achieving 75% or greater adherence.
None of the trials included in this review reported that 75% or
more of the intervention group met the Rock 2012 aerobic exer-
cise guidelines at any given follow-up. Only three trials reported
adherence of 75% or greater to their specified aerobic exercise
prescription (Bourke 2011a; Bourke 2011b; Cadmus 2009). It is
notable that all three incorporated both a supervised and an in-
dependent exercise component as part of their intervention, and
none placed restrictions on the control group in terms of exercise
behaviour. Cadmus 2009 was likely the most successful study re-
garding the promotion of aerobic exercise behaviour, with 75%
of the intervention group reporting between 90 and 119 minutes
per week of moderate intensity exercise, at an average heart rate
of 76% of predicted maximum, for six months. However, of these
three trials, only Bourke 2011a and Bourke 2011b met the Rock
2012 exercise guidelines. Specifically, two to four sets of resistance
exercise at 60% of one repetition max (RM) for eight to 12 rep-
etitions were carried out twice per week for just six weeks. These
three trials all shared the following BCTs.
• Programming a set goal.
• Prompting generalisation of a target behaviour.
• Prompting self-monitoring of behaviour.
• Prompting practise.
Aside from generalisation of a target behaviour, these three in-
terventions did not differ from other interventions in terms of
BCTs reported. Nor did trials explicitly state a theoretical basis.
Other studies such as Daley 2007a and Perna 2010 were much
more comprehensive in their reporting of BCTs and were based
on recognised behaviour change theory. Several trials might have
achieved adherence of 75% or greater, but because of unclear re-
porting, it was not possible to make a judgement on whether this
criterion had been fulfilled. Reasons for judgement of unclear or
unsuccessful adherence are detailed below.
• Daley 2007a: judgement unclear; adherence reported as a
proportion of participants attending a proportion of set exercise
sessions (i.e. 77% of the intervention group attending 70% of
sessions).
• Drouin 2005: judgement unclear; adherence reported as
mean number of days per week when exercise was undertaken,
relative to a range within the prescription (i.e. 3.6 days per week,
when the prescription was for three to five days per week).
• Kaltsatou 2011: judgement unclear; no adherence data
reported.
• Kim 2006: judgement unclear; high adherence was
reported (78%) but in tandem with substantial attrition (i.e. data
missing for 45% of the cohort).
• Pinto 2003: judgement unclear; high adherence was
reported (88%) but in tandem with substantial attrition (i.e.
25% of the intervention group dropped out over the
intervention period).
• Pinto 2005: judgement unsuccessful; 75% adherence
threshold was not met after week 4.
• Pinto 2011: judgement unsuccessful; three-day PAR
questionnaire indicates that 64.7% of the intervention group
and 40.9% of controls were adhering to the exercise guidelines at
three months.
• Hayes 2009: judgement unclear; adherence reported as a
proportion of participants attending a proportion of set exercise
sessions (i.e. 88% allocated to the intervention group participated
in 70% or more of scheduled supervised exercise sessions).
Further, adherence from the unsupervised aspect is not reported.
• McKenzie 2003: judgement unclear; no adherence data
reported.
• Musanti 2012: judgement unclear; high adherence reported
but only 50% of activity logs returned.
• Perna 2010: judgment unclear; women assigned to the
structured intervention completed an average of 83% of their
scheduled hospital-based exercise sessions (4 weeks in total).
Home-based adherence is not clear.
Ideally, ameta-analysis of objectively verified (e.g. using accelerom-
eters or heart rate monitoring) minutes per week of moderate in-
tensity aerobic exercise achieved in an intervention group, com-
pared with controls, for whom the exercise prescription adherence
is at least 75%, would be most informative. Among trials with at
least 75% adherence, only Cadmus 2009 reported behaviour in
these terms. However, this trial demonstrated adherence rates of
75% or more only for 90 to 119 minutes per week of moderate
intensity exercise. The overall mean (standard deviation (SD)) re-
ported for minutes of moderate intensity physical activity at six
months of follow-up was 161.7 (114.7) minutes, as reported by
the 7-Day Physical Activity Log, with adherence reported as 61%.
The other two trials (Bourke 2011a; Bourke 2011b) reported over-
all exercise behaviour using Godin Leisure Index questionnaire
(Godin 1986) scores (without full objective validation). Further,
at the same follow-up point of six months, Bourke 2011b reported
44% attrition and hence was judged as having a high risk of bias.
Bourke 2011a reported outcomes at just 12 weeks of follow-up.
Hence, a meta-analysis of moderate intensity exercise behaviour at
any given follow-up was judged to be not informative. Insuficent
data were available for a synthesis of evidence to be conducted
around free living energy expenditure. Planned subgroup analy-
sis was not deemed informative because of the lack of identified
studies.
Secondary outcomes
A meta-analysis of change in aerobic exercise tolerance was car-
ried out on seven trials that reported these outcomes and also re-
15Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
ported means for final value scores. Standardised mean differences
(SMDs) were used to produce effect estimates as variation in how
trials assessed this outcomewas evident. Standard deviations (SDs)
were calculated from 95% confidence intervals (CIs) using the
formula in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (i.e. SD =
√
N * (upper limit-lower limit)/(t distribution
*2), and from standard errors (SEs) using SD = SE*
√
N, when
they were not reported. Length of follow-up ranged from eight
(Kim 2006; Daley 2007a) to 12 weeks (Bourke 2011a; Bourke
2011b; Musanti 2012; Pinto 2005; Pinto 2011; see Analysis 1.1).
Aerobic exercise tolerance was significantly better in intervention
versus control groups in 330 participants: SMD 0.73, 95% CI
0.51 to 0.95). We then removed trials with a high risk of bias
relative to this outcome and repeated the analysis with the three
remaining trials (Bourke 2011a; Bourke 2011b; Pinto 2005; see
Analysis 1.2); aerobic exercise tolerance was significantly better
in intervention versus control groups in 154 participants: SMD
0.84, 95% CI 0.51 to 1.17). We were unable to analyse subgroups
outlined in the protocol (i.e. by cancer site, type of intervention,
etc) because of a lack of included studies reporting changes in aer-
obic exercise tolerance or fitness. Five trials included data from a
follow-up of six months (Bourke 2011b; Daley 2007a; Kaltsatou
2011; Pinto 2005; Pinto 2011) showing that aerobic exercise tol-
erance was significantly better at six months in intervention versus
control groups in 271 participants: SMD 0.70, 95% CI 0.45 to
0.94; see Analysis 1.3). However, it should be highlighted that
four of these trials have a high risk of bias, which could affect this
outcome at six months, specifically, a high risk of reporting bias
at six months in the Bourke 2011b trial; no adherence data in the
Kaltsatou 2011 trial; substantial contamination among controls
in the Pinto 2011 trial; and non-blinded assessors in the Daley
2007a trial. Note that in all meta-analyses, data from Pinto 2005
have been multiplied by -1 to control for direction of effect (i.e.
lower values in a timed test indicate a better outcome). Data were
extracted from the combined aerobic and resistance training arm
of Musanti 2012.
Brief narrative descriptions of studies not suitable for meta-anal-
yses include the following: Drouin 2005 VO2 peak data are re-
ported as medians and interquartile ranges; for Pinto 2003, no
control group data are presented for the exercise tests.
Three trials that used resistance exercise as a component of the
intervention reported changes in lower (Bourke 2011a; Bourke
2011b) and upper limb (Musanti 2012) strength. All three trials
had reported strength changes at 12 weeks of follow-up, and we
were able to extract means and SDs. Limb strength was signifi-
cantly better in intervention versus control groups for 91 partici-
pants: SMD 0.51, 95% CI 0.19 to 0.93; see Analysis 2.1). After
one trial was removed for high risk of bias (Musanti 2012), the
moderate effect size was still apparent in 68 participants, but it
was no longer significant: SMD 0.47, 95% CI -0.01 to 0.96; see
Analysis 2.2).
Just six trials produced CONSORT diagrams (Bourke 2011a;
Bourke 2011b; Cadmus 2009; Daley 2007a; Pinto 2005; Pinto
2011). Intervention attrition rates from the included trials ranged
from 25% (Pinto 2003) to 0% (Drouin 2005) (median 6%),
with five trials not clearly reporting attrition in the intervention
arm (Kaltsatou 2011; Kim 2006; McKenzie 2003; Musanti 2012;
Perna 2010). Eight trials reported adverse effects (Bourke 2011a;
Bourke 2011b; Cadmus 2009; Daley 2007a; Kim 2006; Musanti
2012; Pinto 2005; Pinto 2011); these ranged from minor (e.g.
musculoskeletal problems; Musanti 2012) to major events (e.g.
death; Kim 2006). However, only one study (Cadmus 2009) was
explicit as to which of these adverse effects were caused by inclu-
sion of the participant in the intervention group (two instances
of plantar fasciitis). The trial recruitment rate ranged from 10%
(Bourke 2011a) to 89% (Perna 2010). Eight trials reported a priori
sample size estimates (Cadmus 2009; Daley 2007a; Hayes 2009;
Kaltsatou 2011; Musanti 2012; Pinto 2003; Pinto 2011; Perna
2010), and only three (Cadmus 2009; Hayes 2009; Perna 2010)
met their recruitment target.
D I S C U S S I O N
Summary of main results
Review findings indicate that currently, convincing evidence are
lacking to suggest that existing exercise interventions are useful for
achieving the Rock 2012 guidelines of 150 minutes per week of
aerobic exercise and twice per week of resistance exercise in seden-
tary cancer cohorts. Adherence to exercise interventions, which
is crucial for understanding treatment dose, is frequently poorly
reported. It is important to note that the fundamental metrics of
exercise behaviour (i.e. frequency, intensity and duration, or repe-
titions, sets and intensity of resistance training), although easy to
devise and report, are seldom included in published clinical trials.
Attempts to reproduce any exercise prescription without detailing
these metrics are fraught with problems; most likely, this is not
possible. The supportive evidence that we have synthesised as a
narrative suggests that interventions that combine supervision of
exercise training in tandem with a requirement for independent
exercise are likely to promote better adherence. Behaviour change
techniques (BCTs) that include programming set goals, prompt-
ing self-monitoring and practicing and generalising behaviour are
a common feature of interventions that have reported better ad-
herence.
Despite the uncertainty surrounding adherence in many of the
included trials, interventions caused improvement in aerobic exer-
cise tolerance at 8 to 12weeks: SMD0.73, 95%CI 0.51 to 0.95) in
intervention participants compared with controls. At six months,
aerobic exercise tolerance was also improved: SMD 0.70, 95% CI
0.45 to 0.94), but it should be noted that four of the five trials
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used in this analysis had a high risk of bias, hence caution is war-
ranted in interpretation of findings. Such improvements could be
interpreted as reassuring that some of the lack of clarity around ad-
herence extends only to reporting issues rather than reflecting real
problems with fidelity. Alternatively, this result could have arisen
from the rapid, relatively large early gains in function expected
in sedentary participants as the result of exercise training, which
could mask smaller changes among non-adherers. Further, aerobic
exercise tolerance should not be considered as definitive evidence
of changes in aerobic fitness (with the accompanying spectrum
of underlying physiological adaptations). It could simply reflect
the fact that individuals have become accustomed to the feeling
of exertion from exercise testing and better tolerance towards per-
ceptions of fatigue. Just one of the included trials (Drouin 2005)
reported using established cardiopulmonary exercise testing pro-
tocols to measure changes in fitness (e.g. VO2 peak derived from
Douglas bag or online gas analysis systems). However, this study
did not report data that we could use in our meta-analysis (i.e.
only medians and ranges were reported). It is interesting to note
that reported attrition over the intervention period for trials in-
cluded in this review was typically low (median 6%), although it is
difficult to interpret adverse effect reports and to identify adverse
effects that are attributable to participation in these interventions.
Overall completeness and applicability of
evidence
This systematic review included 14 trials, all of which were RCTs.
These trials randomly assigned648participants to exercise or com-
parison groups. A large majority of these trials included women
with breast cancer. One trial involved men with advanced prostate
cancer, and two trials involved colorectal cancer survivors. Al-
though these three primary cancers account for most of the pop-
ulation living with and beyond cancer, other common cancers
such as lymphoma and lung cancer do not appear at all in this
review. Less common cancers also are not represented in the ev-
idence base. Furthermore, an overwhelming majority of partici-
pants were white, and only one trial included an ethnically diverse
population. As such, other ethnicities are substantially underrep-
resented. Although we set a limit in this review of 90 minutes per
week of moderate intensity exercise at baseline as the criterion for
categorising participants as “sedentary”, we did not specify any
threshold for vigorous exercisers. It is possible that we could have
included individuals who were performing as much as 90 minutes
per week of vigorous intensity exercise. Such individuals would be
erroneously designated as “sedentary”. However, given the popu-
lation under study, it is likely that such contamination would be
minimal. We set a threshold of 75% adherence for any trial to
be judged “successful” in this review. This decision was based on
previous reports from a review of adherence to exercise schemes
in older adults (Martin 2001). This threshold of course is open to
debate in the context of cancer specifically, but it was believed that
this level represents a minimum for achieving balance between a
meaningful dose of the stated exercise prescription and what is
realistic for most people living with and beyond cancer. Thirteen
of the 14 included trials were conducted in Northern America or
Western Europe, and one trial was completed in Australia. All are
considered high income nations according to the World Health
Organization (WHO) taxonomy. No evidence was derived from
developing countries, and it is uncertain whether the resources
and/or infrastructure required for some of the interventions in-
cluded in this review would be applicable in these parts of the
world.
Although no single tool for measuring physical activity is infallible
(Warren 2010), when possible it is desirable to have self-reported
exercise behaviour supported by objective measurements such as
accelerometers or heart rate data. An overwhelming majority of
trials evaluated non-supervised exercise behaviour by using self-
report logs or seven-day physical activity questionnaires. Whilst
these tools are relatively non-complex and affordable for imple-
mentation in trial design, they are prone to multifarious bias, in-
cluding difficulties in ascertaining the frequency, duration and in-
tensity of physical activity; social desirability bias; the cognitive
demands of recall and overestimation of behaviour, particularly
when such data are used to extrapolate MET/hours of exercise
per week performed, or kcal/wk of energy expenditure. It is ad-
mirable that two trials attempted to validate self-reported inde-
pendent exercise behaviour by using accelerometers (Pinto 2005;
Pinto 2011); however, data either were not supportive of exercise
behaviour recorded by participants or were not reported in their
entirety.
Analysis by behaviour change theory and outcome (e.g. aerobic
exercise tolerance) was not possible given that few trials stated a
theoretical basis for their intervention. It is worthy of note, how-
ever, that interventions frequently consisted of little more than
telling people how to exercise and providing opportunities for this
to occur, with little consideration of the psychological aspects of
changing behaviour. It is also acknowledged that although coding
of BCTs was done primarily on the basis of study reports, it is
possible that some BCTs may have been implemented but not re-
ported. To overcome this possibility and enhance understanding
of the techniques important for changing behaviour in cancer pa-
tients, adoption of the CALO-RE taxonomy or the broader BCT
v1 taxonomy is recommended.
We acknowledge that in this review, we have undertaken a syn-
thesis of RCTs that represent a combination of exercise efficacy
and behaviour change trials (Courneya 2010), and we recognise
the distinction. However, it should be noted by the reader that
all three trials that we judged as successful (i.e. reported 75% or
greater adherence over the intervention period) incorporated in-
tervention elements that were designed to promote independent
exercise behaviour and did not place any restrictions on the con-
trol group in terms of the exercise they were permitted to under-
take during the trial. Finally, we stated in the justification for this
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review that a better understanding of the types of interventions
that could promote long-term, habitual physical activity (i.e. 12
months or longer) in people living with and beyond cancer was
a valuable addition to our knowledge. Unfortunately, because of
limitations in the evidence that we identified, we have not been
able to address this issue. As such, this is an area of uncertainty
that represents an important research gap.
Quality of the evidence
Most of the uncertainty in judging trial bias came from lack of
clarity around randomisation procedures and blinding of study
outcome assessors. Most of the trials in this review were judged
to include at least one element of high risk of non-standard bias,
as described in the ’Other sources of bias’ outcome. Of note, we
chose to refrain from judging trials according to the performance
bias criterion because we considered it not possible to realisti-
cally blind intervention participants to “sham” conditions. Public
health guidelines (e.g. the UK CMO report) for aerobic and resis-
tance exercise (which are identical to the Rock et al recommenda-
tions) are freely available to the public, and given their ease of ac-
cess via the Internet, the validity of a “sham” condition is dubious.
The ’Summary of findings’ and ’Risk of bias’ tables and Figure 2
and Figure 3 provide a summary of the quality of evidence.
Potential biases in the review process
We were not able to translate all non-English language studies
identified through our database, grey literature and snowballing
searches. However, a huge effort was made to identify all relevant
RCTs in this field. To the review authors’ knowledge, we have
identified and evaluated more RCTs involving exercise interven-
tions in people living with or beyond cancer than any other sys-
tematic review in this field. More than 400 papers were screened
at full text stage for eligibility, and we sent 116 emails to request
data to inform the screening and data extraction process, so that
the conclusions of the review would be as accurate and informa-
tive as possible. We were able to perform single extraction only to
generate the CALO-RE taxonomy data (undertaken by LS).
Agreements and disagreements with other
studies or reviews
To the review authors’ knowledge, this is the first comprehensive
review to evaluate RCTs with respect to their success in promoting
exercise behaviour in sedentary cancer cohorts. A recent system-
atic review of predictors of adherence to exercise in people liv-
ing with and beyond cancer (Husebø 2013) found that the trans-
theoretical model of behaviour change and the theory of planned
behaviour were significantly associated with better exercise adher-
ence. The current review does not explicitly support such conclu-
sions. It should be noted that key differences are evident in each
reviewmethodology, with the present review including only RCTs
and people who were sedentary at baseline. Other recent high-
profile systematic reviews (e.g. Fong 2012) have focused on po-
tential health-related outcomes of exercise intervention for people
living with and beyond cancer. In this respect, Fong 2012 similarly
reported improvements in aerobic exercise tolerance and muscle
strength. One substantial difference in the methodology of the
present review when compared with other Cochrane reviews in
this area (e.g. Mishra 2012a; Mishra 2012b) is that we included
only studies in which the essential metrics of exercise behaviour
are reported.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Service provision to promote exercise in sedentary people living
with and beyond cancer should incorporate components of both
supervised and independent exercise requirements. Setting pro-
gramme goals, prompting practise and self-monitoring, and en-
couraging people to attempt to generalise behaviour learned in su-
pervised exercise environments to other non-supervised contexts
are common components of interventions that report meaning-
ful adherence. However, expecting most sedentary survivors to
achieve at least 150 minutes per week of aerobic exercise is likely
to be unrealistic. As with all well-designed exercise programmes in
any context, prescriptions should be designed around individual
capabilities and frequency, duration and intensity or sets, repeti-
tions and intensity, or resistance training should be generated on
this basis. Using these essential metrics of exercise prescription not
only will help achieve a balance between safe yet effective exercise,
but also will ensure that meaningful re-evaluation over time can
be undertaken, as adaptation or disease progression dictates. Rel-
evant training in exercise prescription for people living with and
beyond cancer can be undertaken through established reputable
bodies such as the American College of Sports Medicine, which
runs courses in collaboration with the American Cancer Society.
Implications for research
Recently, in the largest survey of cancer survivors (covering mul-
tiple cancer types) to have been conducted in Europe (N = 3300),
the UK Department of Health reported that less than 25% of
people living with and beyond cancer are achieving 30 minutes
of exercise on five or more days per week (Department of Health
2012). This is a clear indicator that an overwhelming majority of
cancer survivors are not active. It is therefore of critical importance
that:
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• future research is primarily targeted towards a better
understanding of effective promotion of exercise behaviour in
sedentary individuals living with or beyond cancer;
• trials are explicit about baseline exercise behaviour and
about how it was assessed;
• all trials report as standard frequency, intensity and
duration of aerobic exercise, as well as repetitions, sets and
intensity of resistance exercise used in intervention prescriptions;
• standardisation of adherence reporting is achieved in
clinical trials investigating the effects of exercise in cancer
survivors. We recommend that adherence is reported as a single
proportion of the cohort who attended/performed exercise
according to the set prescription;
• accelerometers do not appear to be a helpful tool for
objectively validating exercise behaviour in the trials that we have
reviewed. We recommend the use of heart rate monitoring
during set, purposeful bouts of exercise; and
• reporting of behaviour change techniques employed in such
interventions is standardised. Adoption of the CALO-RE
taxonomy or the broader BCT v1 taxonomy is recommended.
By achieving these standardisations, oncology scientists and clin-
icians will help bring the discipline up to the level of acceptable
rigor that will elucidate dose response of exercise interventions
for given health outcomes. This should afford an opportunity for
practitioners to communicate achievable exercise recommenda-
tions for sedentary people living with and beyond cancer.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bourke 2011a
Methods • Study design: RCT participant level randomisation
• Study location (WHO income taxonomy): Sheffield, UK (high)
• Funding source: Sheffield Hallam University
• Inclusion criteria: patients who had histologically confirmed colon cancer (Dukes
stages A to C) resected 6 to 24 months previously
• Exclusion criteria: existing participation in regular physical activity (purposeful
activity of at least moderate intensity of 30 minutes or longer, three times a week), a
Karnofsky rating of less than 80, unstable angina, uncontrolled hypertension, recent
myocardial infarction or a pacemaker
• CONSORT diagram included: yes
• Number of participants in each arm: 9 intervention, 9 control
• Trial recruitment rate: 18/180
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks
Participants • Primary cancer diagnosis: histologically confirmed colon cancer (Dukes stages A
to C)
• Current cancer treatment: none
• Metastatic disease: none
• Age, years: mean (SD) = control: 70.3 (8.7), intervention: 67.9 (5.7)
• Sex: 12 males, 6 females
• BMI: mean (SD): control: 26.0 (3.5), intervention: 26.9 (3.8)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Group or individual intervention: group
• Setting: university rehabilitation suite
• Exercise prescription components: aerobic and resistance
• Theoretical basis: not stated
• CALO-RE taxonomy components: #15, #16, #26, #27
• Frequency of contact with researchers or exercise professionals: 18 supervised
exercise sessions
• Instructions to controls: continue behaviour as normal
Outcomes • Change in fitness reported: aerobic
exercise tolerance using the Borg treadmill protocol. Resistance
maximal voluntary torque of the knee extensors using isokinetic dynamometry
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: attendance at supervised session with
HR monitors, exercise diaries and Godin LSI at assessment points
• Aerobic exercise frequency: three or more times per week
• Aerobic exercise duration: 30 minutes per session or longer
• Aerobic exercise intensity: intensity of 55% to 85% of age-predicted maximum
28Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
Bourke 2011a (Continued)
heart rate and/or ratings of perceived exertion, 11 to 15/fairly light to hard, on the
Borg Rating Perceived Exertion (RPE) Scale
• Description aerobic exercise mode: cycle/rowing ergometers, treadmill work. Plus
brisk walking, cycling or gym exercise, etc, during independent exercise sessions
• Resistance exercise frequency: three or more times per week
• Resistance exercise sets: between 2 and 4 sets of resistance exercises
• Resistance exercise repetitions: 8 to 12 repetitions
• Resistance exercise intensity: 60% of 1 repetition max
• Description of resistance exercise: Large skeletal muscle groups (quadriceps,
deltoids, pectorals, latissimus dorsi, hamstring muscles) were targeted using body
weight resistance and free weights
Compliance • Intervention uptake: 9/9
• Adherence: Attendance was 146 of 162 of the supervised sessions attended (90%
compliance). The median (range) rating of perceived exertion (Borg RPE scale) during
the exercise sessions was 12 (7 to 16). On average, 94% of the independent exercise
sessions (i.e. participants reporting at least 25 to 30 minutes of aerobic exercise) were
completed
• Attrition: One participant in the intervention arm was lost to follow-up. 89%
completed final follow-up in the intervention arm
• Adverse effects: One stroke in the intervention group occurred but was deemed
unrelated to the study
• Achieves Rock et al guidelines: six weeks of resistance training
Description of usual care Both groups had access to standard care, which consisted of a holistic nurse-led colorectal
cancer follow-up service
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned by an
independent researcher via code numbers
using nQuery statistical software
Allocation concealment (selection bias) Low risk Randomization was undertaken by a senior
academic who was not directly involved in
the recruitment or assessment of partici-
pants
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcomes were assessed by an experi-
enced exercise physiologist, who was blind
to the group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis was used to
compare participants in the groups to
which they were randomly assigned, with
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Bourke 2011a (Continued)
data carried over from previous visits in
cases of participant withdrawal
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk Low recruitment rate (18/180) could rep-
resent a biased sample
Bourke 2011b
Methods • Study design: RCT participant level randomisation
• Study location (WHO income taxonomy): Sheffield, UK (high)
• Funding source: Sheffield Hallam University
• Inclusion criteria: sedentary men with histologically confirmed, non-localised
prostate cancer who had been receiving AST for at least six months
• Exclusion criteria: those with unstable angina, uncontrolled hypertension, recent
myocardial infarction, pacemakers and painful or unstable bony metastases, and those
already undertaking regular physical activity (men engaging in purposeful exercise or
physical activity of at least moderate intensity for 30 minutes or longer, three times per
week), were excluded
• CONSORT diagram included: yes
• Number of participants in each arm: 25 intervention, 25 control
• Trial recruitment rate: 50/78
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 6 months
Participants • Primary cancer diagnosis: prostate cancer T3/T4
• Current cancer treatment: undergoing androgen suppression therapy for a
minimum of six months before
• Metastatic disease: yes
• Age, years, mean (SD): control: 72.2 (7.7), intervention: 71.3 (6.4)
• Sex: male
• BMI: mean (SD): control: 27.4 (2.7), intervention: 28.0 (3.2)
• Ethnicity: 100% white
• Comorbidities reported: unclear
Interventions • Group or individual intervention: group
• Setting: university rehabilitation suite
• Exercise prescription components: aerobic and resistance
• Theoretical basis: not stated
• CALO-RE taxonomy components: #8, #15, #16, #21, #26, #27
• Frequency of contact with researchers or exercise professionals: 18 supervised
exercise sessions
• Instructions given to controls: Men were asked to continue their current exercise/
dietary behaviours as normal
Outcomes • Change in fitness reported: aerobic
exercise tolerance using the Borg treadmill protocol; resistance
maximal voluntary torque of the knee extensors using isokinetic dynamometry
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Bourke 2011b (Continued)
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: attendance at supervised sessions with
heart rate monitors, exercise diaries and Godin LSI questionnaire
• Aerobic exercise frequency: three or more times per week
• Aerobic exercise duration: 30 minutes or longer per session
• Aerobic exercise intensity: intensity of 55% to 85% of age-predicted maximum
heart rate and/or ratings of perceived exertion, 11 to 15/fairly light to hard, on the
Borg Rating of Perceived Exertion (RPE) Scale
• Description of aerobic exercise mode: cycle/rowing ergometers, treadmill work.
Plus brisk walking, cycling and gym exercise
• Resistance exercise frequency: three or more times per week
• Resistance exercise sets: between 2 and 4 sets of resistance exercises
• Resistance exercise repetitions: 8 to 12 repetitions
• Resistance exercise intensity: 60% 1 RM
• Description of resistance exercise: body weight resistance and free weights
targeting large skeletal muscle groups
Compliance • Intervention uptake: 25/25
• Adherence: Attendance at the supervised exercise sessions was 360 of 378 sessions
(95%). Compliance with the self-directed exercise aspect of the lifestyle intervention
was also very good, with 329 of 378 sessions (87%) completed (i.e. participants
reporting in their log books at least 25 to 30 minutes of aerobic exercise)
• Attrition: Four men in the intervention gap at 12 weeks and three men in the
control group at 12 weeks were lost to follow-up. 10 men in the intervention group
failed to complete six-month follow-up, 12 men in the control group failed to
complete six-month follow-up. Overall, 84% and 60% of the intervention arm
completed three and six months of follow-up
• Adverse effects: Two men in the intervention arm were discontinued because of
cardiac complications before the 12-week assessments. Two more reported
musculoskeletal complaints before the six-month assessment. Five men in the control
group reported various health problems that prohibited them from attending the six-
month assessment
• Achieves Rock et al guidelines: 6 weeks of resistance training
Description of usual care Men randomly assigned to standard care were followed up in the urology clinic as normal
and were seen by an oncology nurse specialist and a urologist
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomization was carried out remotely,
using nQuery statistical software (nQuery
Advisor 6.01; Statistical Solutions)
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Bourke 2011b (Continued)
Allocation concealment (selection bias) Low risk Randomization was undertaken by a senior
academic who was not directly involved in
the recruitment or assessment of partici-
pants
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Physiological and functional fitness out-
comes were assessed by a trained technician
blinded to group allocation. Responses on
the self-administered questionnaires were
checked for completeness by the researcher
in the presence of the respondent
Incomplete outcome data (attrition bias)
All outcomes
High risk 44% attrition at six-month postinterven-
tion follow-up
Selective reporting (reporting bias) Low risk None; all outcomes reported
Other bias Low risk None
Cadmus 2009
Methods • Study design: RCT participant level randomisation
• Study location (WHO income taxonomy): US, Connecticut (high)
• Funding source: supported in part by a General Clinical Research Center grant
from the National Center of Research Resources, National Institutes of Health (Grant
# M01-RR00125) awarded to Yale University School of Medicine
• Inclusion criteria: postmenopausal women, aged 40 to 75 years, AJCC Stages 0 to
IIIa breast cancer, 1 to 10 years postdiagnosis, > 12 months postcompletion of adjuvant
treatment, physically able to exercise with physician consent to begin an exercise
programme, sedentary activity pattern (< 60 min/wk) with physician consent to begin
an exercise programme
• Exclusion criteria: diagnosis of recurrent or other primary cancer event. Current
smoker, diabetes mellitus, current or planned enrolment in a structured weight loss
programme
• CONSORT diagram included: yes, in Irwin 2008
• Number of participants in each arm: 37 intervention, 38 control
• Trial recruitment rate: 75/88
• Length of follow-up: length of intervention = 6 months, length of follow-up from
baseline = 6 months
Participants • Primary cancer diagnosis: AJCC Stages 0 to IIIa breast cancer
• Current cancer treatment: completed adjuvant treatment (with the exception of
hormonal therapy) at least six months before enrolment. 57% versus 70% on hormone
therapy in the intervention group versus controls; 30% on tamoxifen in both arms; 27
versus 40% versus control on aromatase inhibitors
• Metastatic disease: none
• Age, years: mean (SD): intervention: 56.5 (9.5), control: 55.1 (7.7)
• Sex: women
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Cadmus 2009 (Continued)
• BMI: mean (SD): intervention: 30.4 (6.0), control: 30.1 (7.4)
• Ethnicity: 84% white in both groups
• Comorbidities reported: unclear
Interventions • Group or individual intervention: supervised and home based
• Setting: a supervised training programme at a local health club. Participants
exercised at the club during designated sessions
• Exercise prescription components: aerobic training
• Theoretical basis: not stated
• CALO-RE taxonomy components: #1, #5, #8. #9, #15, #16, #17, #19, #21, #26,
#29, #35
• Frequency of contact with researchers or exercise professionals: unclear exactly
how many exercise sessions were supervised
• Instructions to controls: Participants assigned to the usual care groups were told
that they could exercise on their own if they chose, but that the study’s physical activity
programme would not be available to them. They received all exercise programme
materials at six-month follow-up
Outcomes • Change in fitness reported: not reported
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: heart rate monitors, physical activity
questionnaire, a seven-day physical activity log and a seven-day pedometer log.
Adherence to the intervention among exercise group participants was assessed by seven-
day physical activity logs weekly
• Aerobic exercise frequency: three sessions per week supervised, two sessions per
week at home or at a health club: total five days a week
• Aerobic exercise duration: participants were asked to perform three 15-minute
sessions during week 1, building to five 30-minute moderate intensity sessions by week
5
• Aerobic exercise intensity: 60% to 80% of maximal heart rate reserve
• Description aerobic exercise mode: From Irwin 2008: The intervention consisted
primarily of walking, an activity preferred by most women and breast cancer survivors,
although participants could choose to meet the exercise goal through swimming,
aerobics, other forms of activity or a combination of different activities. Activities that
did not involve sustained aerobic effort, such as weight lifting and yoga, could be
performed but did not count toward the exercise goal for each week
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 37/37
Adherence:
• Cadmus 2009: Regarding the weekly goals of thrice-weekly supervised exercise
sessions at the health club and twice-weekly unsupervised sessions on their own, women
participated in 67% of the supervised exercise sessions, and 96% of women reported
exercising on their own two other days of the week and exercised on average at 76% of
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Cadmus 2009 (Continued)
their maximal heart rate (82% as a mean over both supervised and unsupervised)
• Irwin 2008: 33% reported 150 minutes/wk of aerobic exercise at an average of
76% HR over the six-month intervention. Women randomly assigned to exercise chose
weight-bearing activities most often, with 82% walking. Few women reported doing
resistance training (3%). 75% of women were doing between 90 and 119 minutes of
moderate intensity exercise per week, over six months
• Latka 2009: The variables that predict adherence were BMI and transtheoretical
model stage of change. Specifically, a lower BMI and a higher degree of readiness to
change physical activity behavior were associated with better adherence
• Attrition: 6 of 75 in total. One participant lost to follow-up in the intervention
group, five lost to follow-up in the control group. 97% completed final follow-up in
the intervention group
• Adverse effects: five of the 37 women randomly assigned to exercise experienced
an adverse effect; two were related to the study (plantar fascitis), and three were
unrelated (swollen Achilles, stress fracture in foot and plantar fasciitis) to the study. No
women developed lymphedema during the study
• Achieves Rock et al guidelines: 33% reported 150 minutes/wk of moderate
intensity aerobic exercise at an average of 76% HR for six months
Description of usual care Unclear
Notes Only YES trial included in the review because of the requirement that participants must
be sedentary at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computer programme randomly assigned
each YES study participant with equal
probability to the exercise group or the
usual care group
Allocation concealment (selection bias) Low risk The randomisation code for each partici-
pant was obtained by the principal inves-
tigator (who was not involved in recruit-
ment or data collection) only after baseline
measures for that individual had been com-
pleted and staff conducting clinic visits did
not have access to the randomisation pro-
gramme
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analyses were conducted according to the
intention-to-treat principle. Baseline QOL
values were carried forward for the five IM-
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Cadmus 2009 (Continued)
PACT study participants (three exercisers
and two controls) and 10 YES study par-
ticipants (five exercisers and five controls)
for whom six-month data were unavailable
Selective reporting (reporting bias) Low risk None, all outcomes reported
Other bias Low risk None
Daley 2007a
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Sheffield, UK (high)
• Funding source: supported by Grant No. CE8304 from Cancer Research UK
• Inclusion criteria: Women who were not regularly active (up to 2 × 20 minute
sessions a week at moderate intensity (researcher had to gauge with client whether it
was moderate intensity
fairly light to somewhat hard) RPE 11 to 13 were used); exercise “pre-contemplators”,
“contemplators” or “preparers” as defined by the transtheoretical model, who had been
treated for localised breast cancer 12 to 36 months previously, were eligible
• Exclusion criteria: Women with metastases and inoperable or active locoregional
disease were ineligible (clinician determined)
• CONSORT diagram included: yes
• Number of participants in each arm: 34; 36; 38 (intervention; sham; control,
respectively)
• Trial recruitment rate: 108/273
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: breast cancer survivors without metastases (inoperable
or active locoregional disease) were ineligible
• Current cancer treatment: 73.5%, 69.4% and 76.3% using hormone therapy in
the intervention, placebo and usual care groups, respectively
• Metastatic disease: none
• Age, years, mean (SD): 51.6 (8.8); 50.6 (8.7); 51.1 (8.6) (intervention; sham;
control, respectively)
• Gender: women
• BMI: mean (SD): 28.5 (4.4); 27.6 (4.1); 29.6 (5.1) (intervention; sham; control,
respectively)
• Ethnicity: two of 108 non-white
• Comorbidities reported: 45/108 had lymphoedema
Interventions • Group or individual intervention: one-to-one supervised sessions
• Setting: university rehabilitation suite
• Exercise prescription components: aerobic
• Theoretical basis: transtheoretical model
• CALO-RE taxonomy components: #1, #5, #8, #9, #10, #13, #16, #17, #18, #20,
#21, #23, #26, #29, #35
• Frequency of contact with researchers or exercise professionals: Every exercise
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Daley 2007a (Continued)
session was supervised
• Instructions to controls: The usual-care group continued with their lives as usual.
The exercise-placebo group attended 24 one-to-one 50-minute sessions during 8
weeks; however, instead of aerobic exercise, they performed light-intensity body
conditioning/stretching (e.g. flexibility, passive stretching) exercises, during which HR
was maintained below 40% heart rate reserve (HR typically was kept below 100 beats
per minute). No exercise counselling or behavioral change advice was provided;
instead, conversations were entered on topics of everyday life (i.e. weather, news items,
and families). HR and RPE were assessed every 5 minutes
Outcomes • Change in fitness reported: Aerobic exercise tolerance was measured using the
submaximal, 8-minute, single-stage walking test performed on a treadmill
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: Adherence was calculated from session
attendance, and the amount (duration, RPE, HR) of exercise achieved by participants
during sessions was calculated by abstraction from physical activity logs maintained by
the researcher
• Aerobic exercise frequency: three sessions per week
• Aerobic exercise duration: 27 minutes of exercise on average per session
• Aerobic exercise intensity: 65% to 85% of age-adjusted HR maximum and RPE
of 12 to 13
• Description aerobic exercise mode: treadmills, rowing ergometers and cycling
ergometers
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 34/34
• Adherence: Adherence to the interventions was excellent; 77% of exercise therapy
and 88.9% of exercise-placebo groups, respectively, attended 70% (at least 17 of 24
sessions) or more of sessions. Mean HR for the exercise therapy group ranged from 117.
4 (SD, 12.9) to 121.5 (SD, 13.4) throughout the weeks. Mean HR for exercise-placebo
ranged from 92.5 (SD, 13.2) to 95.9 (SD, 9.5). Average durations of aerobic exercise
achieved by exercise therapy ranged from 25.7 (SD, 6.3) to 27.4 (SD, 6.2) minutes.
HR data indicated that both groups were exercising in accordance with the protocol
• Attrition: at 8 weeks, 1 ,0 and 5 women were lost to follow-up in the
intervention, sham and control groups, respectively. At 24 weeks, 3, 2 and 7 women
were lost to follow-up in the intervention, sham and control groups, respectively
• Adverse effects: three withdrawals in the intervention group: unclear as to why
this occurred. Some withdrawals due to medical complications in placebo and control
arms, but unclear if study related
• Achieves Rock et al guidelines: no
Description of usual care All participants continue to receive usual care from their health team
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Notes Mean and SD data for aerobic exercise tolerance at 8 and 24 weeks provided by authors
in response to email request
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A telephone randomisation servicewas pro-
vided by an independent trials unit. Ran-
domisation to the three treatment arms was
done on a 1:1:1 ratio and was performed
using stratified random permuted blocks
(with block size of six). Stratification factors
were chemotherapy (yes/no) and tamoxifen
(yes/no)
Allocation concealment (selection bias) Low risk Randomisation service was provided by an
independent trials unit telephone service
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessors were not blinded to par-
ticipants’ group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Little’s D test indicated that missing data
were missing completely at random (2 88.
2; df 1290; P = 0.99). Data were analysed
on an intention-to-treat basis
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): US, Michigan (high)
• Funding source: This study was funded by grants from the Elsa U. Pardee
Foundation in Midland, Michigan, and the Max and Victoria Dreyfus Foundation in
White Plains, New York
• Inclusion criteria: sedentary females (less than 30 minutes of moderate intensity
exercise three times per week), between 20 and 65 years of age, with histologically
established Stage 0 (ductal carcinoma in situ) to III breast cancer, with medical
clearance and signed informed consent
• Exclusion criteria: uncontrolled cardiac or hypertensive disease, orthopaedic
conditions that would limit exercise participation, refusal to accept randomisation or
participation in aerobic exercise within three months before the start of the study.
Medical clearance for this study was determined by the participant’s oncologist, the
results of a routine Multiple Uptake Gated Scan (MUGA) of heart function and a
symptom limited graded exercise test
• CONSORT diagram included: no
• Number of participants in each arm: 13 intervention, 8 placebo stretching
controls
• Trial recruitment rate: 23/39
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 8 weeks
Participants • Primary cancer diagnosis: Stage 0 (ductal carcinoma in situ) to III breast cancer
• Current cancer treatment: Each participant was undergoing external beam
radiation five days per week for seven weeks. The affected breast and regional lymph
nodes received a 4500 to 5000 cGy dose in 200 cGy fractions with a boost of 1000 to
1600 cGy delivered to the primary tumour bed. Treatment dosages were similar
between groups
• Metastatic disease: no
• Age, years: mean (SD): intervention: 49.4 (7.0), controls: 51.9 (10.0)
• Sex: women
• BMI: unclear
• Ethnicity: 13 African American, 8 Caucasian
• Comorbidities reported: not clear
Interventions • Group or individual intervention: unsupervised
members of the aerobic exercise group were instructed to perform self-monitored
walking in their neighbourhood or on a treadmill in their home
• Setting: home-based
• Exercise prescription components: aerobic
• Theoretical basis: not stated
• CALO-RE taxonomy components: #16, #17, #21, #26
• Frequency of contact with researchers or exercise professionals: weekly phone calls
with researcher
• Instructions to controls: Participants in the placebo stretching group were
instructed to perform a general stretching protocol three to five days per week during
this same period. However, the control group was told not to begin any new exercise
activity other than a general flexibility programme that they were given
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Outcomes • Change in fitness reported: VO2 peak assessed before and after intervention
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: All participants were provided a training
diary to record their training adherence in days per week and minutes per day;
members of the intervention group also recorded their training heart rate range. The
principal investigator communicated with all participants weekly in person or by
telephone. Participants in the intervention group wore heart rate monitors to record
training time and time spent in the training heart rate range to improve reporting of
data on exercise compliance, training intensity and training duration
• Aerobic exercise frequency: three to five times per week
• Aerobic exercise duration: 20 to 45 minutes
• Aerobic exercise intensity: Exercise intensity was 50% to 70% of the maximal
heart rate achieved by the participant during a symptom limited graded exercise test
• Description aerobic exercise mode: self-monitored walking in the neighbourhood
or on a treadmill in the home
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 13/13
• Adherence: Participants in the intervention group averaged 3.6 days per week of
aerobic exercise over an 8-week period, and placebo stretching subjects averaged 3.9
days per week of participation during this same time period. No details are available on
what “participation” for the placebo stretching group constituted
• Attrition: Two women were lost to follow-up in the placebo stretching arm. Data
from one participant in the placebo stretching group were eliminated from the final
analysis because of marked irregularities in pretest and post-test physical measures from
moderate to severe fluid retention during the initial test session
• Adverse effects: none reported
• Achieves Rock et al guidelines: unclear
Description of usual care Each participant was treated with external beam radiation five days per week for seven
weeks. The affected breast and regional lymph nodes received a 4500 to 5000 cGy dose
in 200c Gy fractions with a boost of 1000 to 1600 cGy delivered to the primary tumour
bed. Treatment dosages were similar between groups
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A random number table was used
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Drouin 2005 (Continued)
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 of 23 participants lost to follow-up
Selective reporting (reporting bias) Low risk None
Other bias Low risk None
Hayes 2009
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Austrailia (high)
• Funding source: National Breast Cancer Foundation for funding Dr. Hayes’
fellowship
• Inclusion criteria: women younger than 76 years, who had completed treatment
for unilateral breast cancer at least six months before, subsequently had unilateral
upper limb lymphoedema diagnosed by a healthcare professional and were prepared to
travel to the exercise clinic for 12 weeks (if randomly allocated to the intervention
group (IG)) were eligible. All participants were doing < 90 minutes/wk of moderate
intensity exercise (intensity was assessed by RPE)
• Exclusion criteria: no other exclusion criteria were applied
• CONSORT diagram included: no
• Number of participants in each arm: 16 intervention, 16 control
• Trial recruitment rate: 32/138
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: unilateral breast cancer
• Current cancer treatment: none
• Metastatic disease: no
• Age, years: mean (SD): control: 60 (11), intervention 59 (7)
• Sex: women
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: all had lymphoedema
Interventions • Group or individual intervention: a mix of supervised and non-supervised.
Supervised sessions were group based (up to 10 women)
◦ Weeks 1 to 4: three times per week (two supervised)
◦ Weeks 5 to 8: four times per week (two supervised)
◦ Weeks 9 to 12: at least four times per week (one supervised)
• Setting: unclear
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• Exercise prescription components
◦ Weeks 1 to 2: aerobic only (floor-based aerobic exercise to music and
walking)
◦ Weeks 3 to 4: aerobic (floor-based aerobic exercise to music, water-based
aerobic exercise and walking) and water-based resistance exercises
◦ Weeks 5 to 8: aerobic (mix of all types) and water-based and free-weight
resistance exercises
◦ Weeks 9 to 12: aerobic (mix of all types) and machine-weight resistance
exercise
• Theoretical basis: not stated
• CALO-RE taxonomy components: #9, #26
• Frequency of contact with researchers or exercise professionals: 20 supervised
exercise sessions over 12 weeks
• Instructions to controls: The control group was instructed to continue habitual
activities
Outcomes • Change in fitness reported: none
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: Together, exercise adherence rates and
qualitative comments were used to provide insight into the acceptability of the
programme
• Aerobic exercise frequency: three to four or more times per week
• Aerobic exercise duration: 20 to 45+ minutes
• Aerobic exercise intensity: 3 to 7 on a modified Borg scale
• Description aerobic exercise mode: floor-based aerobic exercise to music, water-
based aerobic exercise and walking
• Resistance exercise frequency: three to four or more times per week
• Resistance exercise sets: unclear
• Resistance exercise repetitions: 20 to 10
• Resistance exercise intensity: approximately 15 to 10 repetition max
• Description of resistance exercise: unclear
Compliance • Intervention uptake: 16/16
• Adherence: Most women (88%) allocated to the intervention group participated
in 70% or more of scheduled supervised exercise sessions. The intervention was
scheduled over winter, and missed sessions were most often related to respiratory illness
(n = 10). Other reasons included having a skin lesion removed (n = 1), undergoing
gynaecological surgery (n = 1) and having work commitments (n = 2). One participant
missed 50% of supervised sessions. Unsupervised exercise adherence is unclear
Qualitative quotes:
• “Without having you to guide me, there is no way I would have ever done the
things I’ve done as part of this program”
• “You gave me the confidence to know what I and my arm can do”
• “I would not have tried the things I’ve done if not for the study. I now feel capable
of joining an aqua class”
• “You’ve shown me what I can do rather then tell me what I shouldn’t do”
• Attrition: one participant in each group at 24 weeks
• Adverse effects: none reported
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Hayes 2009 (Continued)
• Achieves Rock et al guidelines: unclear
Description of usual care Physiotherapy, massage, compression, lymphatic drainage or laser therapy for lym-
phoedema
Notes Resistance aspect of this intervention will be excluded from analysis because of unclear
exercise metrics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly allocated us-
ing a computer-generated table of random
numbers
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All measures were assessed pre-intervention
(time 1; T1), immediately postinterven-
tion (time 2; T2) and at 12-week follow-
up (time 3; T3) and were conducted by the
same assessor, who was blinded to partici-
pant group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants (n = 32) participated in T1
and T2, whereas data were unavailable for
two participants (one in the IG and one
in the CG) at T3. To ensure that missing
data did not contribute to the results found,
data analysis was repeated with these two
participants excluded, and no differences in
results were observed (data not shown)
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Adherence data on home-based aspect of
the intervention not clear
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Kaltsatou 2011
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Greece (high)
• Funding source: unclear
• Inclusion criteria: participating only in the dancing exercising programme; none
of the participants had prior physical practise or experience in traditional Greek dances
or were participating in regular moderate intensity exercise. All participants had been
diagnosed and surgically treated for breast cancer. They had completed cancer
therapies, including surgery, radiotherapy and chemotherapy and had stopped all
medical treatments at least three months before the beginning of the study (mean time
post-treatment: 2.2 years)
• Exclusion criteria: included poorly controlled hypertension and any health
condition that would deter the participant from performing the exercises
• CONSORT diagram included: no
• Number of participants in each arm: 14, 13 (intervention vs control)
• Trial recruitment rate: unclear
• Length of follow-up: length of intervention = 24 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: All participants had been diagnosed and surgically
treated for breast cancer
• Current cancer treatment: Participants had completed cancer therapies, including
surgery, radiotherapy and chemotherapy and had stopped all medical treatments at least
three months before the beginning of the study (mean time post-treatment: 2.2 years)
• Metastatic disease: unclear
• Age, years: mean (SD): intervention: 56.6 (4.2), control: 57.1 (4.1)
• Sex: women
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Group or individual intervention: group
• Setting: supervised
• Exercise prescription components: aerobic training with Greek traditional dances,
upper body training and cool-down
• Theoretical basis: not stated
• CALO-RE taxonomy components: #9, #21, #22, #26
• Frequency of contact with researchers or exercise professionals: three supervised
exercise sessions per week
• Instructions to controls: asked to refrain from any form of recreational activity
during the study period
Outcomes • Change in fitness reported: aerobic exercise tolerance assessed by 6-minute walk
test
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: unclear
• Aerobic exercise frequency: three times per week
• Aerobic exercise duration: the aerobic training phase lasted 25 minutes and
included learning and practising Greek traditional dances
• Aerobic exercise intensity: All dances, practised throughout the intervention, were
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Kaltsatou 2011 (Continued)
of moderate intensity (between 65% and 80% of maximum heart rate). Heart rate was
estimated by palpation by participants for four 15-sec periods. Participants also rated
their perceived exertion on a Borg scale. They were encouraged to reach perceived
exertion 13 to 14 on the Borg 6 to 20 category scale. Intensity of exercise was
prescribed on an individual basis, and the workload was progressively increased
• Description aerobic exercise mode: Greek traditional dances
• Resistance exercise frequency: three times per week
• Resistance exercise sets: unclear
• Resistance exercise repetitions: unclear
• Resistance exercise intensity: unclear
• Description of resistance exercise: Upper body exercise training and cool-down
lasted 25 minutes and emphasised stretching and resistance training with the use of
various resistance machines
Compliance • Intervention uptake: unclear
• Adherence: unclear
• Attrition: unclear
• Adverse effects: none reported
• Achieves Rock et al guidelines: unclear
Description of usual care Unclear
Notes Resistance aspect of this intervention will be excluded from analysis because of unclear
exercise metrics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Method of measuring exercise behaviour
and adherence not reported
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): US (high)
• Funding source: supported by an R01 grant from the National Institutes of
Health, National Institute of Nursing Research and a Postdoctoral Fellowship Award
from the Korea Science and Engineering Foundation (KOSEF).
• Inclusion criteria: women newly diagnosed with breast cancer; no history of
cancer; all stages of breast cancer; age 40 years and above; and receiving cancer
treatment
• Exclusion criteria: women with known bony metastasis; high risk of fracture;
known psychiatric illness; uncontrolled cardiopulmonary or other serious medical
condition; and regular exercise at least two to three times a week of moderate intensity
(less than 90 minutes total) within the past two months
• CONSORT diagram included: no
• Number of participants in each arm: 22 intervention,19 control
• Trial recruitment rate: unclear
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: Women with newly diagnosed breast cancer were
stratified by the stage of breast cancer (Stages I to IIB vs locally advanced)
• Current cancer treatment: undergoing treatment
chemotherapy was the most common type of adjuvant therapy (48.8%), followed by
radiotherapy (34.1%) and a combination of chemotherapy and radiotherapy (17.1%)
• Metastatic disease: none
• Age, years: mean (SD): intervention: 51.3 (6.7), controls: 48.3 (8.8)
• Sex: women
• BMI: unclear; 33 women who had significantly higher BMI (34.3 ± 10.2)
excluded from analysis
• Ethnicity: 78% white reported
• Comorbidities reported: unclear
Interventions • Group or individual intervention: unclear
• Setting: cardiac rehabilitation unit with cardiac monitoring until participants
were released to be safe (for n = 2) and an exercise facility within the School of Nursing.
Although most participants continued their exercise intervention in this exercise
facility, a few opted to exercise at home on their own treadmill or to do fast walking
• Exercise prescription components: aerobic
• Theoretical basis: not stated
• CALO-RE taxonomy components: #1, #21, #26, #36
• Frequency of contact with researchers or exercise professionals: supervised exercise
sessions three times per week for the “majority”
• Instructions to controls: Usual care participants were instructed to refrain from
starting a regular or structured exercise programme while participating in the study
Outcomes • Change in fitness reported: changes in VO2 peak at baseline at 8 weeks (although
it is not clear how VO2 was measured)
• Free living energy expenditure: estimate of energy expenditure reported
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Process measures • Method of measuring exercise behaviour: frequency, intensity and duration of
exercise during the 8-week intervention period were monitored using Polar HR
monitors, which were provided to all participants. All participants in both groups
received a seven-day physical activity log to track their levels of exercise/physical
activity over 16 weeks after the eight-week intervention. The seven-day physical
activity log included five categories of the exercise/physical activity level, ranging from
vigorous to sleeping/reclining, with explicit examples given for each level, which made
monitoring feasible for participants. During 16 weeks of the postintervention follow-
up period, the exercise physiologist research member called participants regularly to
collect exercise/physical activity data from the log biweekly for participants in the
intervention group and monthly for participants in the control group. Participants in
the control group received less-frequent calls to minimise unintentional motivation or
a reminder for exercise, but data were recorded at 2-week intervals for both groups
• Aerobic exercise frequency: three days per week
• Aerobic exercise duration: 30 minutes of aerobic exercise and 5 minutes for warm-
up or cool-down
• Aerobic exercise intensity: moderate intensity to produce an HR corresponding to
60% to 70% of the individual’s HR reserve and/or VO2 peak achieved on a graded
exercise test at baseline
• Description aerobic exercise mode: cycling, walking, jogging or running on a
treadmill or track
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: not clear
• Adherence: Average weekly frequency of exercise was 2.4 ± 0.6 sessions, and
average duration of exercise was 42.7 ± 8.0 minutes per session, including warm-up
and cool-down periods. Average duration of exercise within prescribed target HRs was
27.8 ± 8.1 minutes per session. Overall adherence to exercise intervention was 78.3% ±
20.1%, but week-to-week variations over the 8-week intervention period ranged from
68.3% at week 7 to 95.0% at week 3
• Attrition: Of 74 women recruited, 11 women (6 control, 5 intervention)
withdrew from the study. Reasons for withdrawal included personal problems (n = 2),
problems at home (n = 2), problems related to chemotherapy (n = 3), thrombophlebitis
in the lower leg (n = 2), non
exercise-related injuries (n = 1) and death (n = 1). Twenty-two women (12 control
and 10 intervention) missed either a pre-intervention or a postintervention graded
exercise test (GXT), mainly because of scheduling conflicts, not keeping GXT
appointments more than twice or unwillingness to perform the GXT. Forty-one
women completed both pre-intervention and postintervention GXTs (i.e. 41/74)
• Adverse effects: see above
• Achieves Rock et al guidelines: no
Description of usual care Usual cancer care included general information on the benefits of exercise but did not
include specific instructions or further guidance for exercise. Seventy-eight per cent of
women had Stage I and Stage II breast cancer, and chemotherapy was the most common
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type of adjuvant therapy (48.8%), followed by radiotherapy (34.1%) and a combination
of chemotherapy and radiotherapy (17.1%). Regimens of adjuvant therapy most often
consisted of adriamycin 60 mg/m2 and cytoxan 600 mg/m2 every 2 to 3 weeks for 3
doses with or without Taxol 145 mg/m2 every 2 to 3weeks for 3 to 4 doses. Radiotherapy
was typically composed of delivering a total of 45 to 65 Gy over 6 to 7 weeks with
booster doses of 20 Gy
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Data on only 41 of 74 randomly assigned
participants reported
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Women randomly assigned but excluded
had higher BMI and more advanced stages
of cancer
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Canada (high)
• Funding source: supported by the Canadian Breast Cancer Research Initiative
• Inclusion criteria: Participants were eligible for the study if they had undergone
breast cancer treatment for Stage I or II breast cancer that had been completed more
than six months before enrolling in the study and had subsequently developed
unilateral lymphoedema that was greater than 2 cm and less than 8 cm on at least one
measurement point. Participants were not participating in > 90 minutes per week of
moderate intensity exercise
• Exclusion criteria: Stage III lymphoedema, bilateral disease or cases for which
medication was required that might affect upper extremity swelling
• CONSORT diagram included: no
• Number of participants in each arm: 7 intervention, 7 control
• Trial recruitment rate: unclear
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 8 weeks
Participants • Primary cancer diagnosis: Stage I or II breast cancer
• Current cancer treatment: All completed treatment six months before starting the
trial
• Metastatic disease: no
• Age, years: mean (SD): intervention: 56.4 (10.4), control: 56.9 (8.2)
• Sex: women
• BMI: mean (SD): intervention: 29.1 (6.6), control: 25.6 (3.3)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Group or individual intervention: unclear
• Setting: supervised
• Exercise prescription components: aerobic and resistance
• Theoretical basis: not stated
• CALO-RE taxonomy components: #9, #26
• Frequency of contact with researchers or exercise professionals: supervised exercise
sessions three times per week
• Instructions to controls: Control participants were given no specific exercise
instruction until after they completed the study but were specifically asked to refrain
from initiating any new activity
Outcomes • Change in fitness reported: no
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: Work in kilojoules was calculated for
each session for every participant, and this was used to calculate cumulative work done
over the course of the programme
• Aerobic exercise frequency: three days per week (initiated after week 2)
• Aerobic exercise duration: 5 to 20 minutes
• Aerobic exercise intensity: arm cycling at a resistance of 8.3 W to 25 W. Intensity
was also assessed with Polar HR monitors. Target HR was 60% to 80% of maximum
predicted by age
• Description aerobic exercise mode: arm cycling
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• Resistance exercise frequency: three days per week
• Resistance exercise sets: two sets of 10 repetitions for each exercise were done for
the first week, three sets of 10 were done thereafter
• Resistance exercise repetitions: See above
• Resistance exercise intensity: unclear
• Description of resistance exercise: seated row, bench press, latissimus dorsi pull-
down, one arm bent-over rowing, tricep extension, and bicep curl
Compliance • Intervention uptake: unclear
• Adherence: unclear
• Attrition: no attrition reported
• Adverse effects: none reported
• Achieves Rock et al guidelines: no
Description of usual care Unclear
Notes Resistance aspect of this intervention will be excluded from analysis because of unclear
exercise metrics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Adherence to prescribed exercise not re-
ported
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): New Jersey, USA (high)
• Funding source: supported by an award from the Greater NYC Affiliate of the
Susan G. Komen Breast Cancer Foundation, Inc., New York, NY
• Inclusion criteria: Eligible survivors were English-speaking women diagnosed
with Stage I to IIIB breast cancer who had completed adjuvant chemotherapy at least
three months or radiation therapy at least 6 weeks before entry, and who were no more
than 24 months beyond their last treatment. Hormonal therapy could be ongoing
• Exclusion criteria: Women were excluded if medical history or physical
examination revealed evidence of anaemia (haemoglobin <10 mg/dL), uncontrolled
hypertension, congestive heart failure, pulmonary disease, diabetes and thyroid or
musculoskeletal disease. Additional exclusion criteria included current enrolment in a
weight loss or exercise programme or a positive response to any question on the
Physical Activity Readiness Questionnaire, thus indicating the need for medical
clearance before starting an exercise programme
• CONSORT diagram included: no
• Number of participants in each arm: flexibility group (n = 13), aerobic group (n =
12), resistance group (n = 17), aerobic and resistance group (n = 13). Overall N = 55
• Trial recruitment rate: 55/231
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks
Participants • Primary cancer diagnosis: completed adjuvant chemotherapy at least three
months or radiation therapy at least six weeks before entry and were no more than 24
months beyond their last treatment
• Current cancer treatment: hormonal therapy could be ongoing: 56% on hormone
therapy
• Metastatic disease: none
• Age: overall mean (SD) = 50.5 (7.5)
• Sex: women
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Group or supervised intervention: individual
• Setting: home based
• Exercise prescription components: aerobic and resistance exercise
• Theoretical basis: exercise and self-esteem model
• CALO-RE taxonomy components: #9, #16, #17, #21, #22, #26
• Frequency of contact with researchers or exercise professionals: weekly contact via
phone or e-mail. Content included exercise programme adherence, the need for
progression of the exercise prescription and adverse effect reporting
• Instructions to controls: All participants were prescribed flexibility exercise. In-
person verbal instruction plus demonstration was used to teach participants how to do
their assigned exercises. In addition, each participant received a written guidebook that
included general information about exercise participation, such as clothing and safety
tips, as well as their individualised exercise prescription, exercise instructions and an
exercise log sheet
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Outcomes • Change in fitness reported: prediction of VO2 max from submaximal treadmill
testing using the Bruce protocol; change in upper body weight lifted and endurance
reported
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: Adherence to the exercise prescription
was calculated as a proportion of completed sessions over the total possible number of
sessions in the assigned exercise programme. Mean percentage scores were as follows:
flexibility = 85, aerobic = 81, resistance = 91 and aerobic plus resistance = 86. Although
participants were encouraged to complete their exercise log, only 50% of participants
successfully did so
• Aerobic exercise frequency: three times per week. Women who participated in the
aerobic and resistance group followed instructions similar to those given to the aerobic
and resistance only groups; however, the frequency of aerobic exercise progressed to
four to five days per week, and resistance was maintained at two times per week
• Aerobic exercise duration: 15 to 30 minutes
• Aerobic exercise intensity: 40% to 65% of the calculated heart rate max
• Description aerobic exercise mode: walking
• Resistance exercise frequency: times per week. A+R group performed resistance
exercise twice per week
• Resistance exercise sets: one
• Resistance exercise repetitions: Women started with one set of 10 to 12
repetitions. Progression through more resistive bands occurred so that RPE rose to
around seven to eight at the completion of 12 repetitions
• Resistance exercise intensity: Women in the resistance group were prescribed a
Thera-Band that produced an RPE of 3 to 5 on a scale of 0 to 10. Progression through
more resistive bands occurred so that RPE rose to around seven to eight at the
completion of 12 repetitions
• Description of resistance exercise: Women started with one set of 10 to 12
repetitions of the following exercises: shoulder flexion, shoulder press, latissimus pull-
down, seated row, chest press, elbow press (triceps), elbow curl (biceps), hip flexion, hip
extension, abdominal crunches, leg press and squat
Compliance • Intervention uptake: 13/13,12/12,17/17,13/13 for flexibility, aerobic, resistance
and combined groups, respectively
• Adherence: Adherence to the exercise prescription was calculated as a proportion
of completed sessions over the total possible number of sessions in the assigned exercise
programme. Mean percentage scores were as follows: flexibility = 85, aerobic = 81,
resistance = 91 and aerobic plus resistance = 86. Although participants were
encouraged to complete their exercise log, only 50% successfully did so
• Attrition: 42/55. Forty-two women completed the study; however, five of these
women returned the survey data form but refused final fitness testing because of time
constraints related to work and family obligations. Thirteen women (24%) did not
complete their assigned 12-week programme. All dropped out by week 6, except one
woman, who developed appendicitis after the 12-week exercise programme but before
she could complete the postintervention testing. No poststudy assessments were
obtained from these women. The most frequently cited reason given for discontinuing
the exercise programme was perceived difficulty fitting the exercise into their lives
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Musanti 2012 (Continued)
because of work and/or family responsibilities (seven women). One woman had her
breast reconstruction surgery rescheduled so that completion became impossible, one
did not give a reason, and one could not complete the initial fitness testing because of
an elevated HR. Two women cited the need for additional supervised exercise sessions
because they could not maintain motivation on their own
• Adverse effects: Adverse effects were reported in two women during the study. In
both cases, the women developed tendonitis: one in the shoulder and the other in the
foot. Both had a history of tendonitis, and both received standard treatment (i.e. rest,
anti-inflammatory medication, and gentle movement). Both women resumed exercise
at a lesser intensity, progressed their exercise over time and completed the study
without further incident
• Achieves Rock et al guidelines: 12 weeks of resistance exercise at two or three
times per week. Aerobic prescription: unclear
Description of usual care Unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation table
Allocation concealment (selection bias) Low risk Computer-generated randomisation table
maintained by office staff in the clinical re-
search office
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Physical fitness testing was performed at
a hospital-based fitness centre. The same
research assistant, blinded to participant
group allocation, performed thesemeasure-
ments at pre-intervention and postinter-
vention measurement time points
Incomplete outcome data (attrition bias)
All outcomes
High risk Thirteen women (24%) did not complete
their assigned 12-week programme
Selective reporting (reporting bias) High risk Waist, upper and mid and lower arm cir-
cumference measures not reported
Other bias High risk • A significant number of the dropouts
belonged to the resistance exercise group
(n = 8/13). These women did not verbalise
any discontent with this specific modality
of exercise; their reasons for dropping out
were as previously described. Of note,
these women had significantly stronger
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Musanti 2012 (Continued)
muscular endurance measurements than
were reported in the non-dropout group
• Second, significant differences were
noted in baseline levels of fatigue (P = 0.
003), with the dropout group perceiving a
greater level of fatigue. Baseline leisure
time activity was also markedly different.
Women in the completion group reported
a significantly greater weekly volume of
low to moderate physical activity. In the
dropout group, however, scores ranged
from 0 to 12, indicating very little general
activity
• Only 50% of activity logs were
returned
Perna 2010
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Maryland, US (high)
• Funding source: funded by the National Cancer Institute (CA R01-78801)
• Inclusion criteria: (a) English speaking, (b) between 21 and 75 years of age, (c)
sedentary lifestyle (i.e. exercise fewer than three times per week for greater than 30
minutes/session, at a moderate intensity, in last six months), (d) average or below
average fitness as determined by a graded exercise test (GXT) and (e) recent diagnosis
of breast cancer (Stage 0, I, II or IIIa)
• Exclusion criteria: (a) non
cancer-related contraindications to aerobic walking exercise (e.g. symptomatic
coronary artery disease, psychotic spectrum mental illness, orthopaedic problems), (b)
pre-existing metabolic disease (e.g. diabetes, uncontrolled hypertension) and (c) a
contraindication to exercise discovered on the exercise stress test
• CONSORT diagram included: no
• Number of participants in each arm: 51 participants in total. Numbers randomly
assigned to each arm are unclear
• Trial recruitment rate: 51/57
• Length of follow-up: length of intervention = 3 months, length of follow-up from
baseline = 3 months
Participants • Primary cancer diagnosis: breast cancer (Stage 0, I, II or IIIa)
• Current cancer treatment: Most (52.9%) women had Stage I breast cancer and
underwent lumpectomy surgery (74.1%). Many (44.1%) women received both
radiation and chemotherapy, 26.5% received radiation only, 8.8% received
chemotherapy only and 20.6% received no adjuvant therapy
• Metastatic disease: none
• Age, years: overall mean (SD) = 50.8 (11.8)
• Sex: female
• BMI: overall mean (SD): 28.8 (6.1)
• Ethnicity: A large percentage of women were black (44.1%), and total ethnic
minority group membership was high (45.1%)
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Perna 2010 (Continued)
• Comorbidities reported: 23.5% of women had CESD depression scores above the
clinical cut-off
Interventions • Group or supervised intervention: unclear
• Setting: supervised hospital-based and subsequently home-based intervention
• Exercise prescription components: aerobic and resistance
• Theoretical basis: transtheoretical model
• CALO-RE taxonomy components: #1, #5, #8, #9, #10, #12, #15, #16, #19, #20,
#21, #22, #23, #24, #25, #26, #29, #35
• Frequency of contact with researchers or exercise professionals: supervised exercise
sessions three times a week for 4 weeks during hospital phase. Thereafter, intervention
participants received weekly contact by telephone or electronic mail according to
participant preference
• Instructions to controls: Women in the information control group received a 45-
minute session covering their fitness, strength and flexibility assessment results and an
informational brochure. The session specifically excluded discussion of strategies
addressing exercise barriers, and participants who asked about exercise were told to “do
the best you can”. To facilitate participant retention, the control group was contacted
once per month, and one week before follow-up assessment, they were given a
pedometer for data collection purposes (Note: Pedometer data were not part of the
article)
Outcomes • Change in fitness reported: no
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: Participants were provided with
monthly calendars to record their exercise activity and were contacted weekly by
telephone or electronic mail according to their preference. Godin Leisure Time
Exercise Questionnaire and the LTEQ self-report instrument surveys were also used
• Aerobic exercise frequency
◦ Hospital-based phase (first 4 weeks): three times per week
◦ Home-based phase: at least three days per week
• Aerobic exercise duration
◦ Hospital-based phase (first 4 weeks): 15 to 45 minutes
◦ Home-based phase: 30 minutes or longer
• Aerobic exercise intensity
◦ Hospital-based phase: 50% to 85% max HR
◦ Home-based phase: moderate intensity, RPE 11 to 16
• Description aerobic exercise mode: home or treadmill walking
• Resistance exercise frequency
◦ Hospital-based phase: three per week
◦ Home-based phase: Participants were asked to continue resistance training
three times a week
• Resistance exercise sets
◦ Hospital-based phase: 1 to 2 sets
◦ Home-based phase: maintaining the same numbers of sets and repetitions
• Resistance exercise repetitions
◦ Hospital-based phase: 12 to 15
◦ Home-based phase: maintaining the same numbers of sets and repetitions
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Perna 2010 (Continued)
• Resistance exercise intensity
◦ Hospital-based phase: 12 repetitions at the lightest weight, and, as tolerated,
repetitions were increased to 15 after the first week. After a participant could perform
15 repetitions of an exercise, another set was added. Upper body exercises were
performed with a padded weight belt with interchangeable 1.0 lb bars used to adjust
the total weight up to a maximum of 20 lb. Participant body weight was used for lower
body exercises
◦ Home-based phase: maintain
• Description of resistance exercise: The resistance programme consisted of upper
body (bicep curl, triceps extension, chest fly, military press, upright row and shoulder
shrug) and lower body (leg squat and lunge) exercises
Compliance • Intervention uptake: unclear
• Adherence: Women assigned to the structured intervention completed an average
of 83% of their scheduled hospital-based exercise sessions (mean = 9.9, SD = 3.3
sessions), and 76.9% completed all 12 sessions. LTEQ scores increased from baseline
by 157% (from M = 9.7, SD = 8.1 to M = 25.0, SD = 13.1) in the intervention group
and by 32.7% among the control group (fromM = 10.7, SD = 12.8 to M = 14.2, SD =
11.8). Home-based adherence is not clear
• Attrition: unclear. No details on numbers randomly assigned to each arm. An
overall study completion figure of 80.4% is cited (i.e. participants completing follow-
up assessments)
• Adverse effects: unclear
• Achieves Rock et al guidelines: unclear
Description of usual care unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were stratified by cancer stage
and were randomly assigned to groups
Allocation concealment (selection bias) Low risk Participant assignment to groups at enrol-
ment was concealed from the project direc-
tor
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Physicians monitoring graded exercise tests
were blinded to participant group assign-
ment. Similarly, a physical therapist or an
exercise physiologist, blinded to partici-
pant assignment, performed strength as-
sessments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intent-to-treat analysis done and multiple
imputation used
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Selective reporting (reporting bias) Low risk None
Other bias High risk Numbers randomly assigned to interven-
tion and control groups are unclear, as are
numbers completing in each arm
Pinto 2003
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Rhode Island, US (High)
• Funding source: This study was supported by Grant RO3 MH55570 from the
National Institute of Mental Health to Dr Pinto
• Inclusion criteria: Sedentary women (exercised fewer than three times per week
for 20 minutes per session) who had been diagnosed with breast cancer (Stage 0, I or
II) over the past 3 years. Post-surgery patients who had completed chemotherapy or
radiation treatment were invited to participate in a 12-week exercise programme or a
wait-list control group (CG)
• Exclusion criteria: Medical or current psychiatric illness that would make
compliance with the study protocol difficult or dangerous (e.g. coronary artery disease,
hypertension, diabetes), orthopaedic problems or neuropathies that would limit
exercise training. Medications that would alter training responses (e.g. beta blockers) or
affect distress outcomes (e.g. antidepressants) were also reasons for exclusion
• CONSORT diagram included: no
• Number of participants in each arm: 12 in the intervention group versus 12 in the
wait list control group
• Trial recruitment rate: 24/53*
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks
Participants • Primary cancer diagnosis: Stage 0 to II breast cancer, postsurgery participants who
had completed chemotherapy or radiation treatment
• Current cancer treatment: none
• Metastatic disease: none
• Age, years: overall mean (SD): 52.5 (6.8)
• Gender: women
• BMI: overall mean (SD): 26.8 (4.1)
• Ethnicity: all white
• Comorbidities reported: unclear
Interventions • Group or supervised intervention: unclear
• Setting: supervised and home-based exercise
• Exercise prescription components: aerobic and resistance exercise (resistance
exercise was introduced only for last 4 weeks of the 12-week programme)
• Theoretical basis: none
• CALO-RE taxonomy components: #5, #9, #15, #16, #21, #26
• Frequency of contact with researchers or exercise professionals: An exercise
physiologist monitored participants’ blood pressure and heart rate once a week before,
during and after exercise. Individual exercise prescriptions were updated before each
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Pinto 2003 (Continued)
session. Unclear whether physiologist was present at each exercise session
• Instructions to controls: asked not to change their current level of physical activity
Outcomes • Change in fitness reported: aerobic exercise tolerance test performed but no
control group comparison data reported
• Free living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: attendance at supervised exercise
sessions. Individual exercise prescriptions were updated before each session
• Aerobic exercise frequency: three times per week
• Aerobic exercise duration: Over the 12 weeks, the exercise session developed into
10 minutes of warm-up (cardiovascular and flexibility), 10 minutes of cool-down
(cardiovascular and flexibility) and 30 minutes of cardiovascular activity within an
individual’s target heart rate zone
• Aerobic exercise intensity: 60% to 70% of peak heart rate by the end of the 12-
week intervention
• Description aerobic exercise mode: Cardiovascular activities included treadmill
walking, arm and leg ergometers, arm cycling, stationary cycling and rowing. To tailor
the programme for women who had undergone breast surgery and to improve upper
body endurance, investigators encouraged arm cycling and rowing during the sessions.
Participants used at least three modes of physical activity per session that would ensure
at least one cardiovascular arm activity
• Resistance exercise frequency: N/A less than 6 weeks
• Resistance exercise sets: N/A less than 6 weeks
• Resistance exercise repetitions: N/A less than 6 weeks.
• Resistance exercise intensity: N/A less than 6 weeks
• Description of resistance exercise: N/A less than 6 weeks
Compliance • Intervention uptake: unclear
“Three women discontinued participation within the first four weeks of the 12-week
programme”
• Adherence: Of the 12 participants in the exercise group, three women
discontinued participation within the first four weeks of the 12-week programme
(reasons included child care responsibilities and inconvenience of travelling to the
hospital). These individuals provided questionnaire data at postassessments but did not
complete post-treatment exercise tolerance tests. The remaining participants attended a
mean of 88% of the 36-session exercise programme and completed the exercise
tolerance test and questionnaire assessments at post-treatment. Adherence rate to the
home-based component of the exercise prescription was unclear
• Attrition: Nine participants were lost to follow-up (three in the exercise group, six
in the control group)
• Adverse effects: not reported; however, it is unclear why the six controls dropped
out
• Achieves Rock et al guidelines: unclear
Description of usual care Unclear
Notes *We estimated trial recruitment rate on the basis of numbers randomly assigned of those
approached and eligible
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Pinto 2003 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Exercise tolerance test performed but no
control group comparison data reported.
38% lost to follow-up
Selective reporting (reporting bias) High risk None of the physiological assessments were
performed for the control group at 12
weeks
Other bias High risk A statistically significant difference was
noted between groups for body esteem at
baseline (weight concerns and physical
condition subscales)
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Pinto 2005
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Rhode Island, US (high)
• Funding source: supported by National Cancer Institute Grant No. CA 75452
(BMP)
• Inclusion criteria: Eligibility criteria included age 18 years; currently sedentary
(exercised one time per week for 20 minutes at vigorous intensity or two times per
week for 30 minutes at moderate intensity for the past six months)*; diagnosed with
Stage 0 to II breast cancer over the past 5 years; completed surgery, chemotherapy and/
or radiation; ambulatory (able to walk a mile without assistive devices); and willing to
be randomly assigned
• Exclusion criteria: Participants were excluded if they had a prior history of cancer
(exception: non-melanoma skin cancer), or if they had a medical or current psychiatric
illness that could make compliance with the study protocol difficult or dangerous (e.g.
cardiovascular disease, diabetes, orthopaedic problems that limit exercise training)
• CONSORT diagram included: yes
• Number of participants in each arm: 43 in the intervention group and 43 in the
control group
• Trial recruitment rate: 86/123
• Length of follow-up: 12 weeks of “treatment” with nine months of follow-up
from baseline
Participants • Primary cancer diagnosis: breast cancer Stage 0 to II
• Current cancer treatment: 49% of intervention group and 74% of control group
receiving hormone treatment
• Metastatic disease: none
• Age, years: mean (SD): intervention: 53.4 (9.1), control: 52.9 (10.4)
• Sex: women
• BMI: mean (SD): intervention: 27.5 (5.0), control: 28.6 (5.5)
• Ethnicity: 95% white
• Comorbidities reported: unclear
Interventions • Group or supervised intervention: individual
• Setting: home based
• Exercise prescription components: aerobic
• Theoretical basis: transtheoretical model
• CALO-RE taxonomy components: #5, #8, #12, #16, #17, #19
• Frequency of contact with researchers or exercise professionals: After
randomisation, each intervention participant received in-person instructions on how to
exercise at a moderate intensity level, how to monitor heart rate, and how to warm up
before exercise and cool down after exercise. Also, intervention participants received
weekly phone calls for 12 weeks, then calls every month for three months
• Instructions to controls: Control participants were asked to refrain from changing
their current level of activity during the 12 weeks. They received a weekly phone call
from research staff for 12 weeks to match the frequency of contact with the intervention
group. These women received the same cancer survivorship tip sheets as the PA group
Outcomes • Change in fitness reported: aerobic exercise tolerance assessed by a timed one-mile
walk test
• Free living energy expenditure: total weekly energy expenditure (kcal/kg/wk)
calculated from the seven-day physical activity recall questionnaire
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Pinto 2005 (Continued)
Process measures • Method of measuring exercise behaviour: seven-day physical activity recall
questionnaire and accelerometer data providing kcal/h
• Aerobic exercise frequency: two to five days per week
• Aerobic exercise duration: 10 to 30 minutes
• Aerobic exercise intensity: The programme promoted moderate intensity activities
at 55% to 65% of maximum heart rate
• Description of aerobic exercise mode: brisk walking, biking, swimming or use of
home exercise equipment
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 43/43
• Adherence:
◦ Pinto 2005: 15 of 43 in the intervention group and 0 of 41 in the control
group accumulated at least 30 minutes of moderate intensity physical activity (eg,
walking briskly, heavy house work) on most, ideally all, days of the week as reported by
seven-day recall questionnaires. No changes were reported in accelerometer data in the
intervention group (change score = -0.33 kcal/h).
◦ Pinto 2009: from heart rate data: At week 1, participants reported an average
of 43.12 minutes of exercise (SD 44.32) and at week 12, a mean of 128.53 minutes/wk
of exercise (SD 76.82), at between 55% and 65% of predicted max heart rate. However,
less than 75% of the intervention group were meeting the prescribed goal after week 4.
• Attrition: Four dropped out in the intervention arm and did not provide data at
the post-treatment assessment. Reasons for dropout included no time (n = 1); could
not be contacted to determine reasons (n = 2); and participation terminated (n = 1)
(the study team terminated one woman’s participation because of symptoms of chest
pain during exercise and her refusal to have these symptoms evaluated by her physician)
• Adverse effects: not clear whether chest pain was related to exercise in dropout
whose participation was terminated
• Achieves Rock et al guidelines: no
Description of usual care Unclear
Notes *Data from baseline questionnaires indicated that two participants in the intervention
group were active at baseline (i.e. a discrepancy was noted between telephone screening
and assessment). However, the author has advised that outliers were removed during
data analysis of trial outcomes. Author advised that accelerometer data should have been
reported as kcal/h)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
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Pinto 2005 (Continued)
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat approach used and low
attrition reported (5%)
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Significantly more control group partici-
pants were receiving hormone treatment:
49% versus 74% in the intervention and
control groups, respectively (P = 0.015).
Ojective accelerometer data do not sup-
port the self-reported physical activity be-
haviour
Pinto 2011
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Rhode Island, US (high)
• Funding source: This study was funded by the National Cancer Institute (CA
101770 to Dr Pinto)
• Inclusion criteria: (i) Men and women aged ≥ 18 years; (ii) completed primary
and adjuvant treatments for colon or rectal cancer (Stages I to III); (iii) ≤ 5 years since
treatment completion; (iv) able to read and speak English; (v) provided consent for
medical chart review; (vi) able to walk unassisted; (vii) sedentary, which was defined as
exercising < 60 minutes/wk at moderate intensity PA or < 20 minutes/wk of vigorous
intensity PA over the past six months; and (viii) had access to a telephone
• Exclusion criteria: Patients with a prior history of cancer were excluded. Another
exclusion criterion was a medical or current psychiatric illness (e.g. orthopaedic
problems) that could make compliance with the study protocol difficult or unsafe.
Patients with cardiovascular disease and/or diabetes were included if their treating
physicians approved of their study participation
• CONSORT diagram included: yes
• Number of participants in each arm: 20 in the intervention group and 26 in the
control group
• Trial recruitment rate: 46/66
• Length of follow-up: 12 weeks of counselling with 12 months of follow-up from
baseline
Participants • Primary cancer diagnosis: 57% colon cancer, 43% rectal cancer
• Current cancer treatment: none
• Metastatic disease: none
• Age, years: mean (SD): control: 55.6 (8.24), intervention: 59.5 (11.2)
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Pinto 2011 (Continued)
• Gender: 56% female
• BMI: mean (SD): control: 29.4 (6.1), intervention: 27.9 (6.0)
• Ethnicity: 1 of 46 nonwhite
• Comorbidities reported: unclear
Interventions • Group or supervised intervention: individual
• Setting: home based and facilitated with phone calls
• Exercise prescription components: aerobic
• Theoretical basis: transtheoretical model, social cognitive theory
• CALO-RE taxonomy components: #5, #8, #9, #12, #16, #17, #19, #21, #23, #
24, #26
• Frequency of contact with researchers or exercise professionals: After an initial
one-to-one consultation, each participant received a weekly call over 12 weeks from
research staff to monitor physical activity participation, identify relevant health
problems, solve any barriers to physical activity and reinforce participants for their
efforts
• Instructions to controls: were asked not to change their usual level of activity
Outcomes • Change in fitness reported: timed one-mile walk with estimation of VO2 peak
• Free living energy expenditure: calories per week estimated from CHAMPS
questionnaire
Process measures • Method of measuring exercise behaviour: questionnaires
seven-day physical activity recall; community healthy activities model programme for
seniors (CHAMPS); stage of motivational readiness for physical activity. Accelerometer
data also collected
• Aerobic exercise frequency: two to five times per week
• Aerobic exercise duration: 10 to 30 minutes
• Aerobic exercise intensity: The programme promoted moderate intensity aerobic
activities at 64% to 76% of estimated maximum heart rate
• Description aerobic exercise mode: Brisk walking, biking, or use of home exercise
equipment was recommended
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 20/20
• Adherence:
◦ Goal of 150 minutes/wk of PA was met or exceeded by 64.7% of the
intervention group versus 40.9% of the control group at three months, by 38.9% of
the intervention group versus 27.3% of the control group at six months and by 31.6%
of the intervention group versus 21.7% of the control group at 12 months
◦ Physical activity of moderate intensity (recorded using the three-day PAR
questionnaire) was compared with the corresponding accelerometer data over three
days. Spearman rank correlations were weak at baseline (r = 0.12) because of a high
proportion of sedentary participants. Correlation at the three-month follow-up showed
the only significant between-group change reported in exercise minutes: r = 0.32
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Pinto 2011 (Continued)
• Attrition: 1/20 at three, six and 12 months in the intervention arm; 2/26 at three,
3/26 at six and 12 months in the control group
• Adverse effects: one cancer recurrence in the control group at three months
• Achieves Rock et al guidelines: Self-report indicates that 64.7% of the
intervention group and 40.9% of the control group were achieving the guidelines.
However, accelerometer data are not provided to support this. Further, only a weak
correlation was reported between self-report and accelerometer data at three months
Description of usual care Unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a “low”
or “high” risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk < 10% attrition reported
Selective reporting (reporting bias) High risk Accelerometer data not reported
Other bias High risk Accelerometer correlation with self-re-
port questionnaires is weak at follow-up
points when significant differences be-
tween groups in physical activity are re-
ported (i.e. r = 0.32 at 3 months). Substan-
tial contamination in the control group
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ahmed 2006 Sedentary status at baseline is unclear
Ames 2011 Exercise prescription metrics are unclear
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Anderson 2012 Sedentary status at baseline is unclear
Arbane 2011 Author advised that baseline sedentary status was not assessed
Battaglini 2007 Author advised that baseline sedentary status was not assessed
Battaglini 2008 Linked to Battaglini 2007
Campbell 2005 Unclear if participants were meeting the baseline moderate exercise sedentary criteria
Cantarero-Villanueva 2011 Intervention exercise prescription metrics unclear
Cantarero-Villanueva 2012 Linked to Cantarero-Villanueva 2011
Carmack Taylor 2004 Linked to Carmack Taylor 2006
Carmack Taylor 2006 Exercise prescription metrics are unclear
Carmack Taylor 2007 Linked to Carmack Taylor 2006
Carson 2009 Author advised that baseline sedentary status was not assessed
Cho 2006 Sedentary status at baseline is unclear
Coleman 2003 Exercise prescription metrics are unclear
Culos Reed 2010 Exercise prescription metrics are unclear
Danhauer 2009 Sedentary status at baseline is unclear
Daubenmier 2006 Linked to Ornish 2005
DeNysschen 2011 Sedentary status at baseline is unclear
Dolan 2010 START trial includes non sedentary participants
Donnelly 2011 Author advised that cohort was not sedentary at baseline.
Emslie 2007 Linked to Mutrie 2007
Fernandez-Lao 2012 Intervention exercise prescription metrics unclear
Frattaroli 2008 Linked to Ornish 2005
Galvao 2010 Sedentary status at baseline is unclear
Galvao 2011 Linked to Galvao 2010
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Gomez 2011 Cohort not sedentary at baseline
Haines 2010 Sedentary status at baseline is unclear
Hayes 2011 Author advised that baseline sedentary status was not assessed
Headley 2004 Sedentary status at baseline is unclear
Heim 2007 Sedentary status at baseline is unclear
Herrero 2006 Sedentary status at baseline is unclear
Kavanagh 2009 Sedentary status at baseline is unclear
Kilbreath 2006 Sedentary status at baseline is unclear
Kilbreath 2012 Sedentary status at baseline is unclear
Kim 2010 Sedentary status at baseline is unclear
Klinkhammer-Schalke 2012 Sedentary status at baseline is unclear
Ligibel 2008 Author advised that exercise intensity was not clear
Ligibel 2009 Linked to Ligibel 2008
MacVicar 1989 Sedentary status at baseline is unclear
Manassero 2007 Exercise prescription metrics are unclear
McClure 2010 Sedentary status at baseline is unclear
McGuire 2011 Linked to Waltman 2010
McNeely 2004 Author advised that cohort was not sedentary
Mock 1994 Sedentary status at baseline is unclear
Mock 1997 Sedentary status at baseline is unclear
Mock 2005 Sedentary status at baseline is unclear
Monga 2007 Sedentary status at baseline is unclear
Mulero Portela 2008 Author advised that baseline sedentary status was not assessed
Mustian 2008 Exercise prescription metrics are unclear
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Mutrie 2007 Author advised that cohort was not sedentary at baseline
Nieman 1995 Sedentary status at baseline is unclear
Nikander 2007 Sedentary status at baseline is unclear
Ohira 2006 Linked to Schmitz 2005
Ornish 2005 Sedentary status at baseline is unclear
Ornish 2008a Linked to Ornish 2005
Ornish 2008b Linked to Ornish 2005
Payne 2008 Sedentary status at baseline is unclear
Pickett 2002 Sedentary status at baseline is unclear
Rahnama 2010 Author not able to confirm sedentary status
Rogers 2009 Author advised that cohort was not sedentary at baseline
Rogers 2012 Author advised that cohort was not sedentary at baseline
Sandel 2005 Sedentary status at baseline is unclear
Schmitz 2009 Author advised intensity not assessed
Schmitz 2010 Author advised intensity not assessed
Segal 2001 Author advised exercise behavior not formally assessed at baseline
Segal 2003 Author advised exercise behavior not formally assessed at baseline
Segal 2009 Author advised exercise behavior not formally assessed at baseline
von Gruengien 2008 Author advised that cohort was not sedentary at baseline
von Gruengien 2009 Linked to von Gruengien 2008
von Gruengien 2012 Author advised that cohort was not sedentary
Waltman 2010 Author advised that cohort was not sedentary
Wang 2012 Sedentary status at baseline is unclear
Yang 2011 Sedentary status at baseline is unclear
66Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fo
r P
re
vie
w 
On
ly
(Continued)
Yeo 2012 Author not able to clarify exercise metrics
Yuen 2007 Author advised that cohort was not sedentary at baseline
Characteristics of studies awaiting assessment [ordered by study ID]
Bai 2004
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Bai S-M, Ma C, Liu Y-M, Xue W-P, Luo M, Ou Z-H. Effects of cognitive behavior
intervention and cinesiateics on the quality of life of patients with nasopharyngeal carcinoma after radiotherapy.
Chinese Journal of Clinical Rehabilitation 2004;8(29):6312-3
Chen 2010
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Chen J, Luo A, He Y. Influence of postoperative rehabilitation exercises on functional
recovery of ill limb of breast cancer patients. Chinese Nursing Research 2010;24(4A):875-7
Cho 2004
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Cho OH. Effects of a comprehensive rehabilitation programme for mastectomy patients.
Taehan Kanho Hakhoe Chi 2004;34(5):809-19
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Dong 2006
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Dong HY,Wang ZF, Cai L. Correlation between quality of life and rehabilitative guidance
education in the postoperative patients with breast cancer. Chinese Journal of Clinical Rehabilitation 2006; 10(42),
28-30
Guo 2004
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Guo Y-M. Effects of moderate strength and endurance exercise on emotion and quality
of sleep in patients with malignant tumor. Chinese Journal of Clinical Rehabilitation 2004;8(35):7896-7
LeVu 1997
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Le Vu B, Dumortier A, Guillaume MV, Mouriesse H, Barreau-Pouhaer L. Efficacy of
massage and mobilization of the upper limb after surgical treatment of breast cancer. Bulletin du Cancer 1997;80
(10):957-61
Oliveira 2010
Methods
Participants
Interventions
Outcomes
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Oliveira 2010 (Continued)
Notes Study awaiting translation: Oliveira MM, Souza GA, Miranda Mde S, Okubo MA, Amaral MT, Silva MP, Gurgel
MS. Upper limb exercises during radiotherapy for breast cancer and quality of life. Revista Brasileira de Ginecologia
e Obstetrícia 2010;32(3):133-8
Park 2006
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Park HS, Cho GY, Park KY. The effects of a rehabilitation program on physical health,
physiological indicator and quality of life in breast cancer mastectomy patients. Taehan Kanho Hakhoe Chi 2006;36
(2):310-20
Wang 2005
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Wang Y;Yao J-F;Yang J-Y. Effect of rehabilitation exercises on the recovery outcomes of
lung function in postoperative patients with lung cancer. Zhongguo Linchuang Kangfu (Chinese Journal of Clinical
Rehabilitation) 2005; 9(39):14-16
Zhang 2005
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Zhang T, Chang XM, He YG, Huang HX, Fan KS. Effects of rehabilitation therapy in
relieving pain and improving quality of life in patients with advanced cancer. Zhongguo Linchuang Kangfu (Chinese
Journal of Clinical Rehabilitation) 2005;40:59-61
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D A T A A N D A N A L Y S E S
Comparison 1. Aerobic exercise tolerance
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Aerobic exercise tolerance (all
cancers: 8 to 12 weeks of
follow-up)
7 330 Std. Mean Difference (IV, Fixed, 95% CI) 0.73 [0.51, 0.95]
2 Aerobic exercise tolerance (all
cancers: 8 to 12 weeks of
follow-up sensitivity analysis)
3 154 Std. Mean Difference (IV, Fixed, 95% CI) 0.84 [0.51, 1.17]
3 Aerobic exercise tolerance (all
cancers: 6 months)
5 271 Std. Mean Difference (IV, Fixed, 95% CI) 0.70 [0.45, 0.94]
Comparison 2. Strength tests (all cancers)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Strength tests 3 91 Std. Mean Difference (IV, Fixed, 95% CI) 0.51 [0.09, 0.93]
2 Strength tests (all cancers:
sensitivity analysis)
2 68 Std. Mean Difference (IV, Fixed, 95% CI) 0.47 [-0.01, 0.96]
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Analysis 1.1. Comparison 1 Aerobic exercise tolerance, Outcome 1 Aerobic exercise tolerance (all cancers:
8 to 12 weeks of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 1 Aerobic exercise tolerance (all cancers: 8 to 12 weeks of follow-up)
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011a 9 528.2 (114.5) 9 376.7 (125.7) 4.8 % 1.20 [ 0.18, 2.22 ]
Bourke 2011b 25 495.8 (125) 25 379.8 (129.2) 14.8 % 0.90 [ 0.31, 1.48 ]
Daley 2007a 33 35 (4.4) 33 31.5 (5.1) 20.2 % 0.73 [ 0.23, 1.23 ]
Kim 2006 22 1810.1 (369.4) 19 1630.4 (351.5) 12.9 % 0.49 [ -0.14, 1.11 ]
Musanti 2012 11 24.7 (4.1) 12 23 (4.3) 7.4 % 0.39 [ -0.44, 1.22 ]
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 26.3 % 0.74 [ 0.30, 1.17 ]
Pinto 2011 20 27.7 (5.3) 26 23.7 (4.7) 13.7 % 0.79 [ 0.18, 1.40 ]
Total (95% CI) 163 167 100.0 % 0.73 [ 0.51, 0.95 ]
Heterogeneity: Chi2 = 2.40, df = 6 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 6.38 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [control] Favours [experimental]
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Analysis 1.2. Comparison 1 Aerobic exercise tolerance, Outcome 2 Aerobic exercise tolerance (all cancers:
8 to 12 weeks of follow-up sensitivity analysis).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 2 Aerobic exercise tolerance (all cancers: 8 to 12 weeks of follow-up sensitivity analysis)
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011a 9 528.2 (114.5) 9 376.7 (125.7) 10.5 % 1.20 [ 0.18, 2.22 ]
Bourke 2011b 25 495.8 (125) 25 379.8 (129.2) 32.2 % 0.90 [ 0.31, 1.48 ]
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 57.4 % 0.74 [ 0.30, 1.17 ]
Total (95% CI) 77 77 100.0 % 0.84 [ 0.51, 1.17 ]
Heterogeneity: Chi2 = 0.72, df = 2 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 4.95 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [control] Favours [experimental]
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Analysis 1.3. Comparison 1 Aerobic exercise tolerance, Outcome 3 Aerobic exercise tolerance (all cancers:
6 months).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 3 Aerobic exercise tolerance (all cancers: 6 months)
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011b 25 435.8 (118.5) 25 351 (114.4) 18.5 % 0.72 [ 0.14, 1.29 ]
Daley 2007a 31 33.8 (4.8) 31 30.5 (4) 22.9 % 0.74 [ 0.22, 1.25 ]
Kaltsatou 2011 14 483.3 (85.9) 13 403.1 (71.9) 9.4 % 0.98 [ 0.17, 1.78 ]
Pinto 2005 43 -16.79 (1.7) 43 -17.71 (1.6) 32.7 % 0.55 [ 0.12, 0.98 ]
Pinto 2011 20 28.4 (5.5) 26 24.4 (5) 16.6 % 0.75 [ 0.15, 1.36 ]
Total (95% CI) 133 138 100.0 % 0.70 [ 0.45, 0.94 ]
Heterogeneity: Chi2 = 0.96, df = 4 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 5.55 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [control] Favours [experimental]
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Analysis 2.1. Comparison 2 Strength tests (all cancers), Outcome 1 Strength tests.
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 2 Strength tests (all cancers)
Outcome: 1 Strength tests
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011a 9 189.2 (27.7) 9 169 (45.6) 19.7 % 0.51 [ -0.43, 1.45 ]
Bourke 2011b 25 190.3 (40.9) 25 169.2 (48.8) 55.5 % 0.46 [ -0.10, 1.02 ]
Musanti 2012 11 48.3 (14.8) 12 36.75 (20) 24.8 % 0.63 [ -0.21, 1.47 ]
Total (95% CI) 45 46 100.0 % 0.51 [ 0.09, 0.93 ]
Heterogeneity: Chi2 = 0.10, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.40 (P = 0.017)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [control] Favours [experimental]
Analysis 2.2. Comparison 2 Strength tests (all cancers), Outcome 2 Strength tests (all cancers: sensitivity
analysis).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 2 Strength tests (all cancers)
Outcome: 2 Strength tests (all cancers: sensitivity analysis)
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011a 9 189.2 (27.7) 9 169 (45.6) 26.2 % 0.51 [ -0.43, 1.45 ]
Bourke 2011b 25 190.3 (40.9) 25 169.2 (48.8) 73.8 % 0.46 [ -0.10, 1.02 ]
Total (95% CI) 34 34 100.0 % 0.47 [ -0.01, 0.96 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.92 (P = 0.054)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [control] Favours [experimental]
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A D D I T I O N A L T A B L E S
Table 1. Summary of included studies
Study Exercise
components
n Meets Rock
et al guide-
lines?
Adherence
summary
At least 75%
adherence?
High risk of
bias?
Change
in AET re-
ported?
Adverse ef-
fects
Cadmus
2009
Aerobic 37, 38 (in-
tervention
vs control)
33% re-
ported 150
minutes/
wk of mod-
erate inten-
sity aer-
obic exercise
at an aver-
age of 76%
HR, for six
months
75% of
women were
do-
ing between
90 and 119
min-
utes of mod-
erate inten-
sity aerobic
activity per
week at six
months
Yes; for up to
119 minutes
per week
No No Five of the
37
women ran-
domly as-
signed to ex-
ercise expe-
ri-
enced an ad-
verse effect;
two were re-
lated to the
study (plan-
tar fasciitis)
Daley 2007a Aerobic 34,
36, 38 (in-
tervention,
sham, con-
trol, respec-
tively)
No 77% of the
exercise
therapy; at-
tended 70%
(at least 17
of
24 sessions)
or more of
sessions
Unclear Yes;
outcome as-
sessors were
not blinded
to partici-
pants’ group
allocation
Yes Three with-
drawals
in the inter-
ven-
tion group:
unclear as to
why this oc-
curred.
Some with-
drawals be-
cause of
medical
com-
plications in
placebo and
control arms
but unclear
whether
study related
Drouin
2005
Aerobic 13 interven-
tion, 8
placebo
stretching
controls
Unclear Partic-
ipants in the
intervention
group aver-
Unclear No Yes None
reported
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Table 1. Summary of included studies (Continued)
aged
3.6 days per
week of aer-
obic exercise
over an 8-
week period
Kaltsatou
2011
Aerobic 14, 13 (in-
tervention
vs control)
Unclear Not
reported
Not
reported
Yes; method
of mea-
suring exer-
cise and ad-
herence not
reported
No None
reported
Kim 2006 Aerobic 22,19 (in-
tervention
vs control).
No Av-
erage weekly
frequency of
exercise was
2.4 ± 0.6
sessions, and
average du-
ration of ex-
ercise within
prescribed
target HR
was 27.8 ±
8.1 minutes
per session.
Overall ad-
herence was
78.3% ± 20.
1%
Yes Yes;
data missing
for 45% of
the cohort
Yes Reasons for
withdrawal
included
personal
problems
(n = 2),
problems at
home (n =
2), problems
related to
chemother-
apy (n =
3), throm-
bophlebitis
in the lower
leg (n =
2), non
exercise-
related
injuries (n
= 1), and
death (n =
1). Unclear
to which
arm of the
trial these
date relate
Pinto 2003 Aerobic 12, 12 (in-
tervention
vs
control)
Unclear Participants
attended
a mean of
88% of the
36-session
supervised
exercise pro-
Yes Yes; 38%
lost to fol-
low-up. Ex-
ercise toler-
ance test was
performed
but no con-
Yes None
reported;
however, it is
unclear why
the six con-
trols
dropped out
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Table 1. Summary of included studies (Continued)
gramme trol group
comparison
data were re-
ported
Pinto 2005 Aerobic 43, 43 (in-
tervention
vs control)
Unclear At week 12,
inter-
vention par-
ticipants re-
ported
a mean of
128.53 min-
utes/
wk of mod-
erate inten-
sity exercise.
However, no
changes
were re-
ported in the
accelerome-
ter data
in the inter-
vention
group
(change
score = -0.33
kcal/h)
Less than
75% of the
intervention
group
was meeting
the pre-
scribed goal
after week 4
Yes; signifi-
cantly more
control
group
participants
were re-
ceiving hor-
mone treat-
ment.
Accelerom-
eter data do
not support
the self-re-
ported phys-
ical activity
behaviour
Yes Not clear
whether
chest pain
was related
to exercise in
dropout
whose par-
ticipa-
tion was ter-
minated
Pinto 2011 Aerobic 20, 26 (in-
tervention
vs control)
Three-day
PAR ques-
tionnaire in-
dicates that
64.7%
of the inter-
vention
group
and 40.9%
of the con-
trol group
were achiev-
ing the
guidelines at
three
months
Correlation
between
self-re-
ported mod-
erate in-
tensity exer-
cise and ac-
celerom-
eter data at
three-
month fol-
low-up,
when
the only sig-
nificant be-
tween-
group
change is re-
ported: r = 0.
32
No Yes;
accelerome-
ter data were
not re-
ported; also,
cited corre-
lation
is weak (0.
32). Further,
substan-
tial contam-
ination was
noted in the
control
group
Yes One cancer
recurrence
in the con-
trol group at
three
months
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Table 1. Summary of included studies (Continued)
Bourke
2011a
Aerobic and
resistance
9,
9 (interven-
tion vs con-
trol)
Six weeks of
re-
sistance ex-
ercise twice a
week
90% atten-
dance at the
su-
pervised ses-
sions. 94%
of indepen-
dent exercise
sessions
were
completed
Yes No Yes One stroke
in the inter-
vention
group, unre-
lated to the
exercise pro-
gramme
Bourke
2011b
Aerobic and
resistance
25, 25 (in-
tervention
vs control)
Six weeks of
re-
sistance ex-
ercise twice a
week
95% atten-
dance at su-
pervised ex-
ercise ses-
sions. Com-
pliance with
self-di-
rected exer-
cise aspect of
the lifestyle
intervention
was 87%
Yes Yes; high
dropout rate
at postinter-
vention six-
month fol-
low-up
assessment
Yes Two men
in the
intervention
arm were
discontin-
ued because
of cardiac
complica-
tions before
the 12-week
assessments.
Two more
reported
muscu-
loskeletal
complaints
before the
six-month
assessment.
Five men
reported
various
health
problems in
the control
group that
prohibited
them from
attending
the six-
month
assessment
Hayes 2009 Aerobic and
resistance
16, 16 (in-
tervention
vs control)
Unclear Most
women
(88%) allo-
cated to the
intervention
Unclear Yes; ad-
herence data
on unsuper-
vised aspect
of the inter-
No None
reported
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Table 1. Summary of included studies (Continued)
group
participated
in 70% or
more
of scheduled
supervised
exercise ses-
sions
vention are
not clear
McKenzie
2003
Aerobic and
resistance
7,
7 (interven-
tion vs con-
trol)
No Unclear Unclear Yes; adher-
ence to exer-
cise not re-
ported
No None
reported
Musanti
2012
Aerobic and
resistance
Flexibil-
ity group (n
= 13), aero-
bic group (n
= 12), resis-
tance group
(n = 17), aer-
obic and re-
sis-
tance group
(n = 13)
12
weeks of re-
sistance ex-
ercise two or
three times
per week
Mean
percentages
of adherence
were as fol-
lows:
flexibility =
85%, aero-
bic = 81%,
resistance
= 91% and
aerobic plus
resistance =
86%
Unclear Yes; a signifi-
cant number
of dropouts
belonged to
the re-
sistance ex-
ercise group
(n = 8/13)
. Only 50%
of activ-
ity logs were
returned
Yes Adverse
effects were
reported in
two women
during
the study. In
both cases,
the
women de-
veloped ten-
donitis: one
in the shoul-
der and the
other in the
foot. Both
had a his-
tory of ten-
donitis,
and both re-
ceived stan-
dard
treatment
Perna 2010 Aerobic and
resistance
51 par-
ticipants in
total. Num-
bers
randomly
assigned to
each arm are
unclear
Three
months
of resistance
exercise
three times
per week
Women as-
signed to the
structured
intervention
completed
an average of
83% of their
sched-
uled hospi-
tal-based ex-
ercise ses-
sions (only 4
Unclear Yes; num-
bers ran-
domly as-
signed to in-
tervention
and control
groups are
unclear, as
are numbers
completing
in each arm
No Unclear
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Table 1. Summary of included studies (Continued)
weeks in du-
ration), and
76.9% com-
pleted all 12
sessions.
Home-
based com-
ponent (8
weeks in du-
ration)
AET = aerobic exercise tolerance.
Table 2. Behaviour change components
Be-
haviour
change
tech-
nique
Bourke
2011a
Bourke
2011b
Cad-
mus
2009
YALE
Daley
2007a
Drouin
2005
Hayes
2009
Kalt-
satou
2011
McKen-
zie
2003
Mu-
santi
2012
Perna
2010
Kim
2006
Pinto
2003
Pinto
2005
Pinto
2011
The-
ory
TTM
EXSEM
TTM TTM TTM
SCT
1.
Pro-
vide
Info
on
conse-
quences
of be-
haviour
in gen-
eral
X X X X
2.
Pro-
vide
Info
on
conse-
quences
of be-
haviour
to the
indi-
vidual
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Table 2. Behaviour change components (Continued)
3. Pro-
vide
Info
about
oth-
ers’
ap-
proval
4.
Pro-
vide
nor-
ma-
tive
info
about
oth-
ers’
be-
haviour
Pro-
gramme
set
goal
X X X X X X X X X X X X X X
5.
Goal
set-
ting
(be-
haviour)
X X X X X X
6.
Goal
set-
ting
(out-
come)
7. Ac-
tion
plan-
ning
8. Bar-
rier
iden-
X X X X X X
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Table 2. Behaviour change components (Continued)
tifica-
tion/
Prob-
lem
solv-
ing
9. Set-
ting of
graded
tasks
X X X X X X X X X
10.
Prompt
review
of be-
havioural
goals
X X
11.
Prompt
review
of
out-
come
goals
12.
Prompt
re-
wards
con-
tin-
gent
on
effort
or
progress
to-
wards
goal
X X X
13.
Pro-
vide
re-
wards
con-
tin-
X
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Table 2. Behaviour change components (Continued)
gent
on
suc-
cessful
be-
haviour
14.
Shap-
ing
15.
Prompt
gen-
erali-
sation
of a
target
be-
haviour
X X X X X
16.
Prompt
self-
moni-
toring
of be-
haviour
X X X X X X X X X X
17.
Prompt
self-
moni-
toring
of be-
havioural
out-
come
X X X X X X
18.
Prompt
focus
on
past
suc-
cess
X
19.
Feed-
back
X X X X
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Table 2. Behaviour change components (Continued)
on
per-
for-
mance
pro-
vided
20.
Infor-
ma-
tion
pro-
vided
on
where
and
when
to per-
form
be-
haviour
X X
21.
In-
struc-
tion
pro-
vided
on
how
to per-
form
the
be-
haviour
X X X X X X X X X X
22.
Mod-
elling/
Demon-
stra-
tion
of be-
haviour
X X X
23.
Teach-
ing to
use
prompts/
X X X
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Table 2. Behaviour change components (Continued)
cues
24.
Envi-
ron-
men-
tal re-
struc-
turing
X X
25.
Agree-
ment
on be-
havioural
con-
tract
X
26.
Prompt
prac-
tise
X X X X X X X X X X X X X X
27.
Use
of fol-
low-
up
prompts
X X
28.
Facili-
tating
social
com-
pari-
son
29.
Plan-
ning
social
sup-
port/
social
change
X X X
30.
Prompt
iden-
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Table 2. Behaviour change components (Continued)
tifica-
tion
as role
model/
posi-
tion
advo-
cate
31.
Prompt
antici-
pated
regret
32.
Fear
arousal
33.
Prompt
self-
talk
34.
Prompt
use of
im-
agery
35.
Re-
lapse
pre-
ven-
tion/
cop-
ing
plan-
ning
X X
36.
Stress
man-
age-
ment/
emo-
tional
con-
trol
X
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Table 2. Behaviour change components (Continued)
train-
ing
37.
Moti-
va-
tional
inter-
view-
ing
38.
Time
man-
age-
ment
39.
Gen-
eral
com-
muni-
cation
skills
train-
ing
40.
Stim-
ula-
tion of
antici-
pa-
tion of
future
re-
wards
EXSEM = exercise self-esteem model; SCT = social cognitive theory; TTM = transtheroretical model.
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Neoplasms explode all trees
#2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*)
#3 (#1 OR #2)
#4 MeSH descriptor Exercise explode all trees
#5 MeSH descriptor Exercise Movement Techniques explode all trees
#6 MeSH descriptor Exercise Therapy explode all trees
#7 MeSH descriptor Physical Fitness, this term only
#8 (physical* adj5 (fit* or activ*))
#9 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*)
#10 (#4 OR #5 OR #6 OR #7 OR #8 OR #9)
#11 MeSH descriptor Patient Education as Topic, this term only
#12 (educat* or inform* or teach* or supervis* or communicat* or leaflet*)
#13 MeSH descriptor Survivors, this term only
#14 survivor*
#15 MeSH descriptor Behavior Therapy explode all trees
#16 (behaviour* or behavior* or cognit* or CBT)
#17 MeSH descriptor Motivation explode all trees
#18 MeSH descriptor Interview, Psychological, this term only
#19 (motivat* or interview*)
#20 (#11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19)
#21 (#3 AND #10 AND #20)
Appendix 2. MEDLINE search strategy
1. exp Neoplasms/
2. (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3. 1 or 2
4. exp Exercise/
5. exp Exercise Movement Techniques/
6. exp Exercise Therapy/
7. Physical Fitness/
8. (physical* adj5 (fit* or activ*)).mp.
9. (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
10. 4 or 5 or 6 or 7 or 8 or 9
11. Patient Education as Topic/
12. Patient education handout/
13. (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
14. Survivors/ or survivor*.mp.
15. exp Behavior Therapy/
16. (behaviour* or behavior* or cognit* or CBT).mp.
17. exp Motivation/
18. Interview, Psychological/
19. (motivat* or interview*).mp.
20. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
21. 3 and 10 and 20
22. randomized controlled trial.pt.
23. controlled clinical trial.pt.
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24. randomized.ab.
25. placebo.ab.
26. clinical trials as topic.sh.
27. randomly.ab.
28. trial.ti.
29. 22 or 23 or 24 or 25 or 26 or 27 or 28
30. 21 and 29
31. exp animals/ not humans.sh.
32. 30 not 31
key:
mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supple-
mentary concept, unique identifier
pt=publication type
ab=abstract
ti=title
sh=subject heading
Appendix 3. EMBASE search strategy
1 exp neoplasm/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3 1 or 2
4 exp exercise/
5 exp kinesiotherapy/
6 fitness/
7 (physical* adj5 (fit* or activ*)).mp.
8 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
9 4 or 5 or 6 or 7 or 8
10 patient education/
11 (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
12 survivor/ or survivor*.mp.
13 behavior therapy/
14 cognitive therapy/
15 (behaviour* or behavior* or cognit* or CBT).mp.
16 motivation/
17 interview/
18 (motivat* or interview*).mp.
19 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20 3 and 9 and 19
21 crossover procedure/
22 double-blind procedure/
23 randomized controlled trial/
24 single-blind procedure/
25 random*.mp.
26 factorial*.mp.
27 (crossover* or cross over* or cross-over*).mp.
28 placebo*.mp.
29 (double* adj blind*).mp.
30 (singl* adj blind*).mp.
31 assign*.mp.
32 allocat*.mp.
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33 volunteer*.mp.
34 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
35 20 and 34
36 (exp animal/ or nonhuman/ or exp animal experiment/) not human/
37 35 not 36
key:
[mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device
trade name, keyword]
Appendix 4. AMED search strategy
Amed Ovid
1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3 1 or 2
4 exp exercise/
5 exp exercise therapy/
6 physical fitness/
7 (physical* adj5 (fit* or activ*)).mp.
8 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
9 4 or 5 or 6 or 7 or 8
10 exp patient education/
11 (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
12 survivors/ or survivor*.mp.
13 exp behavior therapy/
14 (behaviour* or behavior* or cognit* or CBT).mp.
15 exp motivation/
16 interviews/
17 (motivat* or interview*).mp.
18 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
19 3 and 9 and 18
key:
mp=abstract, heading words, title
Appendix 5. CINAHL search strategy
1 exp NEOPLASMS/
2 (cancer* OR tumor* OR tumour* OR neoplas* OR malignan* OR carcinoma* OR adenocarcinoma* OR choriocarcinoma* OR
leukemia* OR leukaemia* OR metastat* OR sarcoma* OR teratoma*).af
3 1 OR 2
4 exp EXERCISE/
5 exp THERAPEUTIC EXERCISE/
6 exp PHYSICAL FITNESS/
7 (physical* AND (fit* OR activ*)).af
8 (exercis* OR aerobic* OR resistance* OR strength* OR walk* OR endurance*).af
9 4 OR 5 OR 6 OR 7 OR 8
10 exp PATIENT EDUCATION/
11 (educat* OR inform* OR teach* OR supervis* OR communicat* OR leaflet*).af
12 CANCER SURVIVORS/
13 survivor*.af
14 exp BEHAVIOR THERAPY/
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15 (behaviour* OR behavior* OR cognit* OR CBT).af
16 exp MOTIVATION/
17 MOTIVATIONAL INTERVIEWING/
18 (motivat* OR interview*).af
19 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
20 3 AND 9 AND 19
21 RANDOMIZED CONTROLLED TRIALS/
22 20 and 21
Appendix 6. PsycINFO search strategy
PsycINFO Ovid
1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3 1 or 2
4 exp exercise/
5 physical fitness/
6 (physical* adj5 (fit* or activ*)).mp.
7 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
8 4 or 5 or 6 or 7
9 client education/
10 (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
11 survivors/ or survivor*.mp.
12 exp cognitive behavior therapy/
13 exp behavior therapy/
14 (behaviour* or behavior* or cognit* or CBT).mp.
15 exp motivation/
16 motivational interviewing/
17 (motivat* or interview*).mp.
18 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
19 3 and 8 and 18
20 clinical trials/
21 (random* or trial* or group* or placebo*).mp. mp=title, abstract, heading word, table of contents, key concepts, original title, tests
& measures
22 20 or 21
23 19 and 22
key:
[mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures]
Appendix 7. PEDro search strategy
• Title and abstract: “cancer”
• Therapy: fitness training (selected)
• Sub discipline: oncology (selected)
• Method: clinical trial (selected)
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Appendix 8. Cochrane Collaboration’s tool for assessing risk of bias
Random sequence generation
• Low risk of bias (e.g. participants assigned to treatments on basis of a computer-generated random sequence or a table of random
numbers)
• High risk of bias (e.g. participants assigned to treatments on basis of date of birth, clinic ID number or surname, or no attempt to
randomly assign participants)
• Unclear risk of bias (e.g. not reported, information not available)
Allocation concealment
• Low risk of bias (e.g. when the allocation sequence could not be foretold)
• High risk of bias (e.g. allocation sequence could be foretold by participants, investigators or treatment providers)
• Unclear risk of bias (e.g. not reported)
Blinding of participants and personnel
• Low risk of bias, if participants and personnel were adequately blinded
• High risk of bias, if participants were not blinded to the intervention that the participant received
• Unclear risk of bias, if this was not reported or was unclear
Blinding of outcome assessors
• Low risk of bias, if outcome assessors were adequately blinded
• High risk of bias, if outcome assessors were not blinded to the intervention that the participant received
• Unclear risk of bias, if this was not reported or was unclear
Incomplete outcome data
We recorded the proportions of participants whose outcomes were not reported at the end of the study. We coded a satisfactory level
of loss to follow-up for each outcome as follows
• Low risk of bias, if fewer than 20% of participants were lost to follow-up and reasons for loss to follow-up were similar in both
treatment arms
• High risk of bias, if more than 20% of participants were lost to follow-up or reasons for loss to follow-up differed between treatment
arms
• Unclear risk of bias, if loss to follow-up was not reported
Selective reporting of outcomes
• Low risk of bias (e.g. review reports all outcomes specified in the protocol)
• High risk of bias (e.g. if it is suspected that outcomes have been selectively reported)
• Unclear risk of bias (e.g. if it is unclear whether outcomes were selectively reported)
Other bias
• Low risk of bias, if no other source of bias is suspected and the trial appears to be methodologically sound
• High risk of bias, if it is suspected that the trial was prone to an additional bias
• Unclear risk of bias, if uncertainty exists about whether an additional bias may have been present
C O N T R I B U T I O N S O F A U T H O R S
All authors contributed to the design, development and drafting of the protocol for this review. LB and KEH conducted screening and
data extraction, with assistance from DJR and SJCT. LS conducted analysis of the trials according to the CALO-RE taxonomy. MAT,
LS, DJR, KAR, SJCT and JMS assisted with interpretation of results and drafting of the final report. LB led the final report.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• We have highlighted reasons why we contacted corresponding authors and have quantified how many times we attempted to do
this by email (please see Selection of studies; Excluded studies).
• We have provided a justification for exclusion of cross-over trials and for when during the screening process they were screened
out (please see Unit of analysis issues).
• We did not examine funnel plots because too few studies were identified (please see Assessment of risk of bias in included studies).
• We reported only a subset of excluded trials because of the large number of manuscripts that needed to be full text screened and
the large proportion of these that were excluded (please see Excluded studies).
• We highlighted when a manuscript reported insufficient information to allow judgement of an aspect of bias (please see Other
potential sources of bias).
• We were not able to find any trials describing “pattern” of resistance exercise (i.e. the period of rest in between sets) and hence
did not discount any studies for not reporting this. We judged that it would be more informative to include the studies that we found
than to not report on resistance exercise interventions at all.
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